| Year |
Citation |
Score |
| 2023 |
Yalamarty SSK, Filipczak N, Pathrikar T, Cotter C, Ataide JA, Paranjape S, Torchilin V. Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model. Research Square. PMID 38168301 DOI: 10.21203/rs.3.rs-3713164/v1 |
0.352 |
|
| 2023 |
Davatgaran Taghipour Y, Salehi R, Zarebkohan A, Zakeri Z, Khordadmehr M, Saeedi Honar Y, Torchilin VP. Dual targeting salinomycin-loaded smart nanomicelles for enhanced accumulation and therapeutic outcome in breast cancer. International Journal of Pharmaceutics. 642: 123095. PMID 37268031 DOI: 10.1016/j.ijpharm.2023.123095 |
0.363 |
|
| 2023 |
Subhan MA, Parveen F, Filipczak N, Yalamarty SSK, Torchilin VP. Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis. Journal of Personalized Medicine. 13. PMID 36983571 DOI: 10.3390/jpm13030389 |
0.327 |
|
| 2023 |
Subhan MA, Torchilin VP. Biopolymer-Based Nanosystems for siRNA Drug Delivery to Solid Tumors including Breast Cancer. Pharmaceutics. 15. PMID 36678782 DOI: 10.3390/pharmaceutics15010153 |
0.347 |
|
| 2022 |
Khan MM, Torchilin VP. Recent Trends in Nanomedicine-Based Strategies to Overcome Multidrug Resistance in Tumors. Cancers. 14. PMID 36077660 DOI: 10.3390/cancers14174123 |
0.325 |
|
| 2022 |
Yalamarty SSK, Filipczak N, Li X, Pathrikar TV, Cotter C, Torchilin VP. Co-Delivery of siRNA and Chemotherapeutic Drug Using 2C5 Antibody-Targeted Dendrimer-Based Mixed Micelles for Multidrug Resistant Cancers. Pharmaceutics. 14. PMID 35890364 DOI: 10.3390/pharmaceutics14071470 |
0.372 |
|
| 2022 |
Taghipour YD, Zarebkohan A, Salehi R, Rahimi F, Torchilin VP, Hamblin MR, Seifalian A. An update on dual targeting strategy for cancer treatment. Journal of Controlled Release : Official Journal of the Controlled Release Society. 349: 67-96. PMID 35779656 DOI: 10.1016/j.jconrel.2022.06.044 |
0.345 |
|
| 2021 |
Filipczak N, Joshi U, Attia SA, Fridman IB, Cohen S, Konry T, Torchilin V. Hypoxia-sensitive drug delivery to tumors. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 34838607 DOI: 10.1016/j.jconrel.2021.11.034 |
0.379 |
|
| 2021 |
Subhan MA, Torchilin VP. Neutrophils as an emerging therapeutic target and tool for cancer therapy. Life Sciences. 285: 119952. PMID 34520766 DOI: 10.1016/j.lfs.2021.119952 |
0.309 |
|
| 2021 |
Raval N, Maheshwari R, Shukla H, Kalia K, Torchilin VP, Tekade RK. Multifunctional polymeric micellar nanomedicine in the diagnosis and treatment of cancer. Materials Science & Engineering. C, Materials For Biological Applications. 126: 112186. PMID 34082985 DOI: 10.1016/j.msec.2021.112186 |
0.312 |
|
| 2021 |
Subhan MA, Attia SA, Torchilin VP. Advances in siRNA delivery strategies for the treatment of MDR cancer. Life Sciences. 274: 119337. PMID 33713664 DOI: 10.1016/j.lfs.2021.119337 |
0.34 |
|
| 2020 |
Khan MM, Filipczak N, Torchilin VP. Cell penetrating peptides: A versatile vector for co-delivery of drug and genes in cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33248708 DOI: 10.1016/j.jconrel.2020.11.028 |
0.362 |
|
| 2020 |
Campos PM, Praça FG, Mussi SV, Figueiredo SA, Fantini MCA, Fonseca MJV, Torchilin VP, Bentley MVLB. Liquid crystalline nanodispersion functionalized with cell-penetrating peptides improves skin penetration and anti-inflammatory effect of lipoic acid after in vivo skin exposure to UVB radiation. Drug Delivery and Translational Research. PMID 32803561 DOI: 10.1007/S13346-020-00840-2 |
0.365 |
|
| 2020 |
Zhang X, Pan J, Yao M, Palmerston Mendes L, Sarisozen C, Mao S, Torchilin VP. Charge reversible hyaluronic acid-modified dendrimer-based nanoparticles for siMDR-1 and doxorubicin co-delivery. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 32645383 DOI: 10.1016/J.Ejpb.2020.06.019 |
0.439 |
|
| 2020 |
Filipczak N, Pan J, Yalamarty SSK, Torchilin VP. Recent advancements in liposome technology. Advanced Drug Delivery Reviews. PMID 32593642 DOI: 10.1016/J.Addr.2020.06.022 |
0.433 |
|
| 2020 |
Subhan MA, Torchilin VP. siRNA based drug design, quality, delivery and clinical translation. Nanomedicine : Nanotechnology, Biology, and Medicine. 29: 102239. PMID 32544449 DOI: 10.1016/J.Nano.2020.102239 |
0.442 |
|
| 2020 |
Khan MM, Madni A, Filipczak N, Pan J, Rehman M, Rai N, Attia SA, Torchilin VP. Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacy. Nanomedicine : Nanotechnology, Biology, and Medicine. 102228. PMID 32485321 DOI: 10.1016/J.Nano.2020.102228 |
0.447 |
|
| 2020 |
Pan J, Attia SA, Subhan MA, Filipczak N, Palmerston Mendes L, Li X, Yalamarty SSK, Torchilin VP. Monoclonal antibody 2C5-modified mixed dendrimer micelles for tumor-targeted co-delivery of chemotherapeutics and siRNA. Molecular Pharmaceutics. PMID 32233497 DOI: 10.1021/Acs.Molpharmaceut.0C00075 |
0.461 |
|
| 2020 |
Mensah SA, Nersesyan AA, Harding IC, Lee CI, Tan X, Banerjee S, Niedre M, Torchilin VP, Ebong EE. Flow-regulated endothelial glycocalyx determines metastatic cancer cell activity. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 32167209 DOI: 10.1096/Fj.201901920R |
0.328 |
|
| 2020 |
Mutlu-Agardan NB, Sarisozen C, Torchilin VP. Cytotoxicity of Novel Redox Sensitive PEG-S-S-PTX Micelles against Drug-Resistant Ovarian and Breast Cancer Cells. Pharmaceutical Research. 37: 65. PMID 32166361 DOI: 10.1007/S11095-020-2759-4 |
0.452 |
|
| 2019 |
Bhatt H, Kiran Rompicharla SV, Ghosh B, Torchilin V, Biswas S. Transferrin/α-tocopherol modified poly(amidoamine) dendrimers for improved tumor targeting and anticancer activity of paclitaxel. Nanomedicine (London, England). 14: 3159-3176. PMID 31855118 DOI: 10.2217/Nnm-2019-0128 |
0.448 |
|
| 2019 |
Filipczak N, Jaromin A, Piwoni A, Mahmud M, Sarisozen C, Torchilin V, Gubernator J. A Triple Co-Delivery Liposomal Carrier That Enhances Apoptosis via an Intrinsic Pathway in Melanoma Cells. Cancers. 11. PMID 31835393 DOI: 10.3390/Cancers11121982 |
0.419 |
|
| 2019 |
Subhan MA, Torchilin VP. Efficient nanocarriers of siRNA therapeutics for cancer treatment. Translational Research : the Journal of Laboratory and Clinical Medicine. 214: 62-91. PMID 31369717 DOI: 10.1016/J.Trsl.2019.07.006 |
0.474 |
|
| 2019 |
Mensah SA, Harding IC, Zhang M, Jaeggli MP, Torchilin VP, Niedre MJ, Ebong EE. Metastatic cancer cell attachment to endothelium is promoted by endothelial glycocalyx sialic acid degradation. Aiche Journal. American Institute of Chemical Engineers. 65. PMID 31367063 DOI: 10.1002/Aic.16634 |
0.373 |
|
| 2019 |
Khan MM, Madni A, Torchilin V, Filipczak N, Pan J, Tahir N, Shah H. Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin. Drug Delivery. 26: 765-772. PMID 31357896 DOI: 10.1080/10717544.2019.1642420 |
0.429 |
|
| 2019 |
Hussein W, Cheong Y, Liu C, Liu G, Begum A, Attallah MA, Moyle PM, Torchilin V, Smith R, Toth I. Peptide-based targeted polymeric nanoparticles for siRNA delivery. Nanotechnology. PMID 31295734 DOI: 10.1088/1361-6528/Ab313D |
0.413 |
|
| 2019 |
Costa DF, Sarisozen C, Torchilin VP. Synthesis of Doxorubicin and miRNA Stimuli-Sensitive Conjugates for Combination Therapy. Methods in Molecular Biology (Clifton, N.J.). 1974: 99-109. PMID 31098998 DOI: 10.1007/978-1-4939-9220-1_8 |
0.338 |
|
| 2019 |
Mendes LP, Sarisozen C, Luther E, Pan J, Torchilin VP. Surface-engineered polyethyleneimine-modified liposomes as novel carrier of siRNA and chemotherapeutics for combination treatment of drug-resistant cancers. Drug Delivery. 26: 443-458. PMID 30929529 DOI: 10.1080/10717544.2019.1574935 |
0.45 |
|
| 2019 |
Pan J, Rostamizadeh K, Filipczak N, Torchilin VP. Polymeric Co-Delivery Systems in Cancer Treatment: An Overview on Component Drugs' Dosage Ratio Effect. Molecules (Basel, Switzerland). 24. PMID 30875934 DOI: 10.3390/Molecules24061035 |
0.465 |
|
| 2019 |
Narayanaswamy R, Torchilin VP. Hydrogels and Their Applications in Targeted Drug Delivery. Molecules (Basel, Switzerland). 24. PMID 30744011 DOI: 10.3390/Molecules24030603 |
0.426 |
|
| 2019 |
Sarisozen C, Tan Y, Liu J, Bilir C, Shen L, Filipzcak N, Porter TM, Torchilin VP. MDM2 antagonist-loaded targeted micelles in combination with doxorubicin: effective synergism against human glioblastoma via p53 re-activation. Journal of Drug Targeting. 1-31. PMID 30656973 DOI: 10.1080/1061186X.2019.1570518 |
0.358 |
|
| 2019 |
Pan J, Palmerston Mendes L, Yao M, Filipczak N, Garai S, Thakur GA, Sarisozen C, Torchilin VP. Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 30633973 DOI: 10.1016/J.Ejpb.2019.01.006 |
0.457 |
|
| 2018 |
Jhaveri A, Luther E, Torchilin V. The effect of transferrin-targeted, resveratrol-loaded liposomes on neurosphere cultures of glioblastoma: Implications for targeting tumor-initiating cells. Journal of Drug Targeting. 1-43. PMID 30475084 DOI: 10.1080/1061186X.2018.1550647 |
0.44 |
|
| 2018 |
El-Sawy HS, Al-Abd AM, Ahmed TA, El-Say KM, Torchilin VP. Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives. Acs Nano. PMID 30335963 DOI: 10.1021/Acsnano.8B06104 |
0.41 |
|
| 2018 |
Costa DF, Mendes LP, Torchilin VP. The effect of Low- and High-Penetration Light on Localized Cancer Therapy. Advanced Drug Delivery Reviews. PMID 30217518 DOI: 10.1016/J.Addr.2018.09.004 |
0.424 |
|
| 2018 |
Costa DF, Torchilin VP. Micelle-like nanoparticles as siRNA and miRNA carriers for cancer therapy. Biomedical Microdevices. 20: 59. PMID 29998417 DOI: 10.1007/S10544-018-0298-0 |
0.374 |
|
| 2018 |
Mutlu Agardan NB, Sarisozen C, Torchilin VP. Redox-triggered intracellular siRNA delivery. Chemical Communications (Cambridge, England). PMID 29869650 DOI: 10.1039/C8Cc01376D |
0.429 |
|
| 2018 |
Joanitti GA, Sawant RS, Torchilin VP, Freitas SM, Azevedo RB. Optimizing liposomes for delivery of Bowman-Birk protease inhibitors - Platforms for multiple biomedical applications. Colloids and Surfaces. B, Biointerfaces. 167: 474-482. PMID 29723819 DOI: 10.1016/J.Colsurfb.2018.04.033 |
0.382 |
|
| 2018 |
Upponi JR, Jerajani K, Nagesha DK, Kulkarni P, Sridhar S, Ferris C, Torchilin VP. Polymeric micelles: Theranostic co-delivery system for poorly water-soluble drugs and contrast agents. Biomaterials. 170: 26-36. PMID 29649747 DOI: 10.1016/J.Biomaterials.2018.03.054 |
0.422 |
|
| 2018 |
Jhaveri A, Deshpande P, Pattni B, Torchilin V. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 29522834 DOI: 10.1016/J.Jconrel.2018.03.006 |
0.49 |
|
| 2018 |
Deshpande P, Jhaveri A, Pattni B, Biswas S, Torchilin V. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer. Drug Delivery. 25: 517-532. PMID 29433357 DOI: 10.1080/10717544.2018.1435747 |
0.472 |
|
| 2017 |
Wang T, Narayanaswamy R, Ren H, Gillespie JW, Petrenko VA, Torchilin VP. Phage-Derived Protein-Mediated Targeted Chemotherapy of Pancreatic Cancer. Journal of Drug Targeting. 1-24. PMID 29132246 DOI: 10.1080/1061186X.2017.1405424 |
0.46 |
|
| 2017 |
Kumar G, Goldberg SN, Gourevitch S, Levchenko T, Torchilin V, Galun E, Ahmed M. Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation. Radiology. 162943. PMID 28880787 DOI: 10.1148/Radiol.2017162943 |
0.303 |
|
| 2017 |
Pattni BS, Jhaveri A, Dutta I, Baleja JD, Degterev A, Torchilin V. Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG. International Journal of Pharmaceutics. PMID 28844900 DOI: 10.1016/J.Ijpharm.2017.08.095 |
0.397 |
|
| 2017 |
Palmerston Mendes L, Pan J, Torchilin VP. Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy. Molecules (Basel, Switzerland). 22. PMID 28832535 DOI: 10.3390/Molecules22091401 |
0.459 |
|
| 2017 |
Muddineti OS, Kumari P, Ghosh B, Torchilin VP, Biswas S. d-α-Tocopheryl Succinate/Phosphatidyl Ethanolamine Conjugated Amphiphilic Polymer-Based Nanomicellar System for the Efficient Delivery of Curcumin and To Overcome Multiple Drug Resistance in Cancer. Acs Applied Materials & Interfaces. PMID 28504884 DOI: 10.1021/Acsami.7B01087 |
0.452 |
|
| 2017 |
Kohay H, Sarisozen C, Sawant R, Jhaveri A, Torchilin VP, Mishael YG. PEG-PE/Clay Composite Carriers for Doxorubicin: Effect of Composite Structure on Release, Cell Interaction and Cytotoxicity. Acta Biomaterialia. PMID 28400314 DOI: 10.1016/J.Actbio.2017.04.008 |
0.393 |
|
| 2017 |
Luther E, Mendes LP, Pan J, Costa DF, Torchilin VP. Applications of label-free, quantitative phase holographic imaging cytometry to the development of multi-specific nanoscale pharmaceutical formulations. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. PMID 28371272 DOI: 10.1002/Cyto.A.23102 |
0.388 |
|
| 2017 |
Vladimirov YA, Sarisozen C, Vladimirov GK, Filipczak N, Polimova AM, Torchilin VP. The Cytotoxic Action of Cytochrome C/Cardiolipin Nanocomplex (Cyt-CL) on Cancer Cells in Culture. Pharmaceutical Research. PMID 28321609 DOI: 10.1007/S11095-017-2143-1 |
0.371 |
|
| 2017 |
Aryasomayajula B, Salzano G, Torchilin VP. Multifunctional Liposomes. Methods in Molecular Biology (Clifton, N.J.). 1530: 41-61. PMID 28150195 DOI: 10.1007/978-1-4939-6646-2_3 |
0.37 |
|
| 2017 |
Erdogan S, Torchilin VP. Gadolinium-Loaded Polychelating Polymer-Containing Tumor-Targeted Liposomes. Methods in Molecular Biology (Clifton, N.J.). 1522: 179-192. PMID 27837539 DOI: 10.1007/978-1-4939-6591-5_14 |
0.421 |
|
| 2017 |
Jhaveri A, Torchilin V. Abstract B34: Resveratrol in transferrin-modified liposomes for eliminating both, bulk tumor cells and tumor-initiating cells in glioblastoma Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-B34 |
0.489 |
|
| 2017 |
Luther E, Mendes L, Costa D, Pan J, Holden E, Torchilin V. Abstract B18: A label-free, high content, moderate throughput analytical platform for quantitative kinetic analysis of cell behavior upon drug activation in cell-culture models based on the Kolmogorov-Smirnov test Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-B18 |
0.375 |
|
| 2017 |
Luther E, Mendes L, Pan J, Holden E, Torchilin V. Abstract 4553: Development of a 4-sample version of the Kolmogorov-Smirnov test for evaluating the temporal physiology of cells treated with test compounds in a label-free, high content, platform for quantitative analysis of adherent cell-culture models Cancer Research. 77: 4553-4553. DOI: 10.1158/1538-7445.Am2017-4553 |
0.33 |
|
| 2017 |
Jhaveri A, Torchilin V. Abstract 3251: Evaluating the efficacy of transferrin-targeted, resveratrol-loaded liposomes in treating glioblastoma Cancer Research. 77: 3251-3251. DOI: 10.1158/1538-7445.Am2017-3251 |
0.477 |
|
| 2017 |
Sriraman SK, Salzano G, Torchilin V. Drug Delivery to the Central Nervous System Primer On Cerebrovascular Diseases. 198-201. DOI: 10.1016/B978-0-12-803058-5.00041-2 |
0.376 |
|
| 2017 |
Sarisozen C, Pan J, Dutta I, Torchilin VP. Polymers in the co-delivery of siRNA and anticancer drugs to treat multidrug-resistant tumors Journal of Pharmaceutical Investigation. 47: 37-49. DOI: 10.1007/S40005-016-0296-2 |
0.427 |
|
| 2016 |
Yilmaz C, Sarisozen C, Torchilin V, Busnaina A. Novel Nanoprinting for Oral Delivery of Poorly Soluble Drugs. Methodist Debakey Cardiovascular Journal. 12: 157-162. PMID 27826370 DOI: 10.14797/Mdcj-12-3-157 |
0.419 |
|
| 2016 |
Zou W, Sarisozen C, Torchilin VP. The reversal of multidrug resistance in ovarian carcinoma cells by co-application of tariquidar and paclitaxel in transferrin-targeted polymeric micelles. Journal of Drug Targeting. 1-32. PMID 27616277 DOI: 10.1080/1061186X.2016.1236113 |
0.412 |
|
| 2016 |
Pattni BS, Nagelli SG, Aryasomayajula B, Deshpande PP, Kulkarni A, Hartner WC, Thakur G, Degterev A, Torchilin VP. Erratum to: Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model. Pharmaceutical Research. PMID 27599990 DOI: 10.1007/S11095-016-2034-X |
0.461 |
|
| 2016 |
Sarisozen C, Dhokai S, Tsikudo EG, Luther E, Rachman IM, Torchilin VP. Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 27569031 DOI: 10.1016/J.Ejpb.2016.08.013 |
0.437 |
|
| 2016 |
Oliveira MS, Aryasomayajula B, Pattni B, Mussi SV, Ferreira LA, Torchilin VP. Solid Lipid Nanoparticles Co-Loaded with Doxorubicin and α-Tocopherol succinate are effective against drug-resistant cancer cells in monolayer and 3-D spheroid cancer cell models. International Journal of Pharmaceutics. PMID 27568499 DOI: 10.1016/j.ijpharm.2016.08.049 |
0.361 |
|
| 2016 |
Sánchez-Purrà M, Ramos V, Petrenko VA, Torchilin VP, Borrós S. Double-targeted polymersomes and liposomes for multiple barrier crossing in cancer. International Journal of Pharmaceutics. PMID 27498281 DOI: 10.1016/J.Ijpharm.2016.08.001 |
0.457 |
|
| 2016 |
Zhang Y, Sriraman SK, Kenny HA, Luther E, Torchilin V, Lengyel E. Reversal of chemoresistance in ovarian cancer by co-delivery of a P-glycoprotein inhibitor and paclitaxel in a liposomal platform. Molecular Cancer Therapeutics. PMID 27466355 DOI: 10.1158/1535-7163.Mct-15-0986 |
0.369 |
|
| 2016 |
Salzano G, Costa DF, Sarisozen C, Luther E, Mattheolabakis G, Dhargalkar PP, Torchilin VP. Mixed Nanosized Polymeric Micelles as Promoter of Doxorubicin and miRNA-34a Co-Delivery Triggered by Dual Stimuli in Tumor Tissue. Small (Weinheim An Der Bergstrasse, Germany). PMID 27432595 DOI: 10.1002/Smll.201600925 |
0.34 |
|
| 2016 |
Pattni BS, Nagelli SG, Aryasomayajula B, Deshpande PP, Kulkarni A, Hartner WC, Thakur G, Degterev A, Torchilin VP. Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model. Pharmaceutical Research. PMID 27351426 DOI: 10.1007/s11095-016-1978-1 |
0.355 |
|
| 2016 |
Sriraman SK, Salzano G, Sarisozen C, Torchilin V. Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 105: 40-9. PMID 27264717 DOI: 10.1016/J.Ejpb.2016.05.023 |
0.481 |
|
| 2016 |
Wang T, Narayanaswamy R, Ren H, Torchilin VP. Combination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment. Cancer Biology & Therapy. 0. PMID 27259361 DOI: 10.1080/15384047.2016.1190488 |
0.368 |
|
| 2016 |
Sarisozen C, Salzano G, Torchilin VP. Lipid-based siRNA Delivery Systems: Challenges, Promises and Solutions Along the Long Journey. Current Pharmaceutical Biotechnology. 17: 728-40. PMID 27033509 DOI: 10.2174/1389201017666160401145319 |
0.365 |
|
| 2016 |
Riehle R, Pattni B, Jhaveri A, Kulkarni A, Thakur G, Degterev A, Torchilin V. Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA. Pharmaceutical Research. PMID 26951567 DOI: 10.1007/S11095-016-1899-Z |
0.798 |
|
| 2016 |
Klauber TC, Søndergaard RV, Sawant RR, Torchilin VP, Andresen TL. Elucidating the role of free polycations in gene knockdown by siRNA polyplexes. Acta Biomaterialia. 35: 248-59. PMID 26884277 DOI: 10.1016/J.Actbio.2016.02.021 |
0.386 |
|
| 2016 |
Sriraman SK, Pan J, Sarisozen C, Luther E, Torchilin V. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells. Molecular Pharmaceutics. PMID 26702994 DOI: 10.1021/Acs.Molpharmaceut.5B00663 |
0.408 |
|
| 2016 |
Perche F, Biswas S, Patel NR, Torchilin VP. Hypoxia-Responsive Copolymer for siRNA Delivery. Methods in Molecular Biology (Clifton, N.J.). 1372: 139-62. PMID 26530922 DOI: 10.1007/978-1-4939-3148-4_12 |
0.693 |
|
| 2016 |
Narayanaswamy R, Wang T, Torchilin VP. Improving Peptide Applications Using Nanotechnology. Current Topics in Medicinal Chemistry. 16: 253-70. PMID 26279082 DOI: 10.2174/1568026615666150817100338 |
0.332 |
|
| 2015 |
Sabhachandani P, Motwani V, Cohen N, Sarkar S, Torchilin V, Konry T. Generation and functional assessment of 3D multicellular spheroids in droplet based microfluidics platform. Lab On a Chip. PMID 26686985 DOI: 10.1039/C5Lc01139F |
0.396 |
|
| 2015 |
Sarisozen C, Salzano G, Torchilin VP. Recent advances in siRNA delivery. Biomolecular Concepts. 6: 321-41. PMID 26609865 DOI: 10.1515/Bmc-2015-0019 |
0.307 |
|
| 2015 |
Sriraman SK, Geraldo V, Luther E, Degterev A, Torchilin V. Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro. Journal of Controlled Release : Official Journal of the Controlled Release Society. 220: 160-8. PMID 26497930 DOI: 10.1016/J.Jconrel.2015.10.037 |
0.453 |
|
| 2015 |
Salzano G, Costa DF, Torchilin VP. siRNA Delivery by Stimuli-Sensitive Nanocarriers. Current Pharmaceutical Design. 21: 4566-73. PMID 26486143 DOI: 10.2174/138161282131151013190410 |
0.336 |
|
| 2015 |
Kitatani K, Usui T, Sriraman SK, Toyoshima M, Ishibashi M, Shigeta S, Nagase S, Sakamoto M, Ogiso H, Okazaki T, Hannun YA, Torchilin VP, Yaegashi N. Ceramide limits phosphatidylinositol-3-kinase C2β-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid. Oncogene. PMID 26364609 DOI: 10.1038/Onc.2015.330 |
0.386 |
|
| 2015 |
Jhaveri A, Torchilin V. Intracellular delivery of nanocarriers and targeting to subcellular organelles. Expert Opinion On Drug Delivery. 13: 49-70. PMID 26358656 DOI: 10.1517/17425247.2015.1086745 |
0.42 |
|
| 2015 |
Al-Abd AM, Aljehani ZK, Gazzaz RW, Fakhri SH, Jabbad AH, Alahdal AM, Torchilin VP. Pharmacokinetic strategies to improve drug penetration and entrapment within solid tumors. Journal of Controlled Release : Official Journal of the Controlled Release Society. 219: 269-77. PMID 26342660 DOI: 10.1016/J.Jconrel.2015.08.055 |
0.39 |
|
| 2015 |
Mussi SV, Parekh G, Pattekari P, Levchenko T, Lvov Y, Ferreira LA, Torchilin VP. Improved pharmacokinetics and enhanced tumor growth inhibition using a nanostructured lipid carrier loaded with doxorubicin and modified with a layer-by-layer polyelectrolyte coating. International Journal of Pharmaceutics. 495: 186-93. PMID 26325314 DOI: 10.1016/J.Ijpharm.2015.08.079 |
0.391 |
|
| 2015 |
Salzano G, Torchilin VP. Intracellular Delivery of Nanoparticles with Cell Penetrating Peptides. Methods in Molecular Biology (Clifton, N.J.). 1324: 357-68. PMID 26202282 DOI: 10.1007/978-1-4939-2806-4_24 |
0.348 |
|
| 2015 |
Ahmed M, Kumar G, Navarro G, Wang Y, Gourevitch S, Moussa MH, Rozenblum N, Levchenko T, Galun E, Torchilin VP, Goldberg SN. Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy. Plos One. 10: e0128910. PMID 26154425 DOI: 10.1371/Journal.Pone.0128910 |
0.371 |
|
| 2015 |
Al-Abd AM, Al-Abbasi FA, Torchilin VP. Intratumoral Pharmacokinetics: Challenges to Nanobiomaterials. Current Pharmaceutical Design. 21: 3208-14. PMID 26027565 DOI: 10.2174/1381612821666150531170621 |
0.375 |
|
| 2015 |
Pattni BS, Chupin VV, Torchilin VP. New Developments in Liposomal Drug Delivery. Chemical Reviews. 115: 10938-66. PMID 26010257 DOI: 10.1021/Acs.Chemrev.5B00046 |
0.382 |
|
| 2015 |
Patel NR, Aryasomayajula B, Abouzeid AH, Torchilin VP. Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems. Therapeutic Delivery. 6: 509-20. PMID 25996047 DOI: 10.4155/Tde.15.1 |
0.8 |
|
| 2015 |
Movassaghian S, Merkel OM, Torchilin VP. Applications of polymer micelles for imaging and drug delivery. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 7: 691-707. PMID 25683687 DOI: 10.1002/Wnan.1332 |
0.462 |
|
| 2015 |
Salzano G, Navarro G, Trivedi MS, De Rosa G, Torchilin VP. Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer. Molecular Cancer Therapeutics. 14: 1075-84. PMID 25657335 DOI: 10.1158/1535-7163.Mct-14-0556 |
0.443 |
|
| 2015 |
Navarro G, Pan J, Torchilin VP. Micelle-like nanoparticles as carriers for DNA and siRNA. Molecular Pharmaceutics. 12: 301-13. PMID 25557580 DOI: 10.1021/Mp5007213 |
0.362 |
|
| 2015 |
Essex S, Navarro G, Sabhachandani P, Chordia A, Trivedi M, Movassaghian S, Torchilin VP. Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors. Gene Therapy. 22: 257-66. PMID 25354685 DOI: 10.1038/Gt.2014.97 |
0.394 |
|
| 2015 |
Sriraman SK, Zhang Y, Luther E, Lengyel E, Torchilin V. Abstract 4416: Reversal of chemoresistance in ovarian cancer cells by the liposomal co-delivery of MDR inhibitors and paclitaxel Cancer Research. 75: 4416-4416. DOI: 10.1158/1538-7445.Am2015-4416 |
0.463 |
|
| 2015 |
Luther E, Salzano G, Sriraman SK, Costa D, Torchilin VP. Abstract LB-A22: Comparison of the effect of pharmaceutical compounds on tumor cells in 2D and 3D in vitro models using label-free, quantitative 4 dimensional holographic imaging Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-Lb-A22 |
0.364 |
|
| 2014 |
Kommagalla Y, Cornea S, Riehle R, Torchilin V, Degterev A, Ramana CV. Optimization of the anti-cancer activity of phosphatidylinositol-3 kinase pathway inhibitor PITENIN-1: switching a thiourea with 1,2,3-triazole. Medchemcomm. 5: 1359-1363. PMID 25505943 DOI: 10.1039/C4Md00109E |
0.789 |
|
| 2014 |
Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nature Reviews. Drug Discovery. 13: 813-27. PMID 25287120 DOI: 10.1038/Nrd4333 |
0.435 |
|
| 2014 |
Wang T, Yang S, Mei LA, Parmar CK, Gillespie JW, Praveen KP, Petrenko VA, Torchilin VP. Paclitaxel-loaded PEG-PE-based micellar nanopreparations targeted with tumor-specific landscape phage fusion protein enhance apoptosis and efficiently reduce tumors. Molecular Cancer Therapeutics. 13: 2864-75. PMID 25239936 DOI: 10.1158/1535-7163.Mct-14-0052 |
0.484 |
|
| 2014 |
Moussa M, Goldberg SN, Kumar G, Sawant RR, Levchenko T, Torchilin VP, Ahmed M. Nanodrug-enhanced radiofrequency tumor ablation: effect of micellar or liposomal carrier on drug delivery and treatment efficacy. Plos One. 9: e102727. PMID 25133740 DOI: 10.1371/Journal.Pone.0102727 |
0.428 |
|
| 2014 |
Sriraman SK, Aryasomayajula B, Torchilin VP. Barriers to drug delivery in solid tumors. Tissue Barriers. 2: e29528. PMID 25068098 DOI: 10.4161/Tisb.29528 |
0.434 |
|
| 2014 |
Sarisozen C, Abouzeid AH, Torchilin VP. The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 88: 539-50. PMID 25016976 DOI: 10.1016/J.Ejpb.2014.07.001 |
0.841 |
|
| 2014 |
Torchilin V. Intracellular delivery of protein and peptide therapeutics. Drug Discovery Today. Technologies. 5: e95-e103. PMID 24981097 DOI: 10.1016/J.Ddtec.2009.01.002 |
0.395 |
|
| 2014 |
Memanishvili T, Zavradashvili N, Kupatadze N, Tugushi D, Gverdtsiteli M, Torchilin VP, Wandrey C, Baldi L, Manoli SS, Katsarava R. Arginine-based biodegradable ether-ester polymers with low cytotoxicity as potential gene carriers. Biomacromolecules. 15: 2839-48. PMID 24963693 DOI: 10.1021/Bm5005977 |
0.331 |
|
| 2014 |
Lukianova-Hleb EY, Ren X, Sawant RR, Wu X, Torchilin VP, Lapotko DO. On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles. Nature Medicine. 20: 778-84. PMID 24880615 DOI: 10.1038/Nm.3484 |
0.392 |
|
| 2014 |
Jhaveri A, Deshpande P, Torchilin V. Stimuli-sensitive nanopreparations for combination cancer therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. 190: 352-70. PMID 24818767 DOI: 10.1016/J.Jconrel.2014.05.002 |
0.453 |
|
| 2014 |
Jhaveri AM, Torchilin VP. Multifunctional polymeric micelles for delivery of drugs and siRNA. Frontiers in Pharmacology. 5: 77. PMID 24795633 DOI: 10.3389/Fphar.2014.00077 |
0.475 |
|
| 2014 |
Pappalardo JS, Langellotti CA, Di Giacomo S, Olivera V, Quattrocchi V, Zamorano PI, Hartner WC, Levchenko TS, Torchilin VP. In vitro transfection of bone marrow-derived dendritic cells with TATp-liposomes International Journal of Nanomedicine. 9: 963-973. PMID 24611012 DOI: 10.2147/Ijn.S53432 |
0.349 |
|
| 2014 |
Perche F, Biswas S, Wang T, Zhu L, Torchilin VP. Hypoxia-targeted siRNA delivery. Angewandte Chemie (International Ed. in English). 53: 3362-6. PMID 24554550 DOI: 10.1002/Anie.201308368 |
0.408 |
|
| 2014 |
Zhu L, Perche F, Wang T, Torchilin VP. Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs. Biomaterials. 35: 4213-22. PMID 24529391 DOI: 10.1016/J.Biomaterials.2014.01.060 |
0.45 |
|
| 2014 |
Abouzeid AH, Patel NR, Sarisozen C, Torchilin VP. Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells. Pharmaceutical Research. 31: 1938-45. PMID 24522815 DOI: 10.1007/S11095-013-1295-X |
0.807 |
|
| 2014 |
Mussi SV, Sawant R, Perche F, Oliveira MC, Azevedo RB, Ferreira LA, Torchilin VP. Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells. Pharmaceutical Research. 31: 1882-92. PMID 24522814 DOI: 10.1007/S11095-013-1290-2 |
0.432 |
|
| 2014 |
Parekh G, Pattekari P, Joshi C, Shutava T, DeCoster M, Levchenko T, Torchilin V, Lvov Y. Layer-by-layer nanoencapsulation of camptothecin with improved activity International Journal of Pharmaceutics. 465: 218-227. PMID 24508806 DOI: 10.1016/J.Ijpharm.2014.01.041 |
0.368 |
|
| 2014 |
Abouzeid AH, Patel NR, Torchilin VP. Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer. International Journal of Pharmaceutics. 464: 178-84. PMID 24440402 DOI: 10.1016/J.Ijpharm.2014.01.009 |
0.813 |
|
| 2014 |
Sawant RR, Jhaveri AM, Koshkaryev A, Zhu L, Qureshi F, Torchilin VP. Targeted transferrin-modified polymeric micelles: enhanced efficacy in vitro and in vivo in ovarian carcinoma. Molecular Pharmaceutics. 11: 375-81. PMID 24325630 DOI: 10.1021/Mp300633F |
0.45 |
|
| 2014 |
Biswas S, Torchilin VP. Nanopreparations for organelle-specific delivery in cancer. Advanced Drug Delivery Reviews. 66: 26-41. PMID 24270008 DOI: 10.1016/J.Addr.2013.11.004 |
0.499 |
|
| 2014 |
Apte A, Koren E, Koshkaryev A, Torchilin VP. Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models. Cancer Biology & Therapy. 15: 69-80. PMID 24145298 DOI: 10.4161/Cbt.26609 |
0.835 |
|
| 2014 |
Wang T, Hartner WC, Gillespie JW, Praveen KP, Yang S, Mei LA, Petrenko VA, Torchilin VP. Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 421-30. PMID 24028893 DOI: 10.1016/J.Nano.2013.08.009 |
0.456 |
|
| 2014 |
Navarro G, Essex S, Sawant RR, Biswas S, Nagesha D, Sridhar S, de ILarduya CT, Torchilin VP. Phospholipid-modified polyethylenimine-based nanopreparations for siRNA-mediated gene silencing: implications for transfection and the role of lipid components. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 411-9. PMID 23928214 DOI: 10.1016/J.Nano.2013.07.016 |
0.341 |
|
| 2014 |
Abouzeid AH, Patel NR, Rachman IM, Senn S, Torchilin VP. Nanotechnology-based treatment for chemotherapy-resistant breast cancer Proceedings of Spie. 9166: 916606. DOI: 10.1117/12.2064660 |
0.826 |
|
| 2014 |
Lukianova-Hleb EY, Ren X, Sawant RR, Gillenwater AM, Kupferman M, Hanna EY, Zasadzinski JA, Wu X, Torchilin VP, Lapotko DO. Plasmonic nanobubble theranostics for intra-operative and preventive treatment of head and neck squamous cell carcinoma Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8926. DOI: 10.1117/12.2038277 |
0.387 |
|
| 2014 |
Kozlowska D, Biswas S, Fox EK, Wu B, Bolster F, Edupuganti OP, Torchilin V, Eustace S, Botta M, O'Kennedy R, Brougham DF. Gadolinium-loaded polychelating amphiphilic polymer as an enhanced MRI contrast agent for human multiple myeloma and non Hodgkin's lymphoma (human Burkitt's lymphoma) Rsc Advances. 4: 18007. DOI: 10.1039/C3Ra45400B |
0.329 |
|
| 2014 |
Sydow K, Torchilin VP, Dathe M. Lipopeptide-modified PEG-PE-based pharmaceutical nanocarriers for enhanced uptake in blood-brain barrier cells and improved cytotoxicity against glioma cells European Journal of Lipid Science and Technology. 116: 1174-1183. DOI: 10.1002/Ejlt.201300373 |
0.466 |
|
| 2013 |
Mussi SV, Torchilin VP. Recent trends in the use of lipidic nanoparticles as pharmaceutical carriers for cancer therapy and diagnostics. Journal of Materials Chemistry. B. 1: 5201-5209. PMID 32263326 DOI: 10.1039/C3Tb20990C |
0.43 |
|
| 2013 |
Biswas S, Torchilin VP. Dendrimers for siRNA Delivery. Pharmaceuticals (Basel, Switzerland). 6: 161-83. PMID 24275946 DOI: 10.3390/Ph6020161 |
0.356 |
|
| 2013 |
D'Arrigo G, Navarro G, Di Meo C, Matricardi P, Torchilin V. Gellan gum nanohydrogel containing anti-inflammatory and anti-cancer drugs: a multi-drug delivery system for a combination therapy in cancer treatment. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 87: 208-16. PMID 24215783 DOI: 10.1016/J.Ejpb.2013.11.001 |
0.434 |
|
| 2013 |
Salzano G, Riehle R, Navarro G, Perche F, De Rosa G, Torchilin VP. Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer. Cancer Letters. 343: 224-31. PMID 24099916 DOI: 10.1016/j.canlet.2013.09.037 |
0.359 |
|
| 2013 |
Abouzeid AH, Patel NR, Rachman IM, Senn S, Torchilin VP. Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin. Journal of Drug Targeting. 21: 994-1000. PMID 24098980 DOI: 10.3109/1061186X.2013.840639 |
0.805 |
|
| 2013 |
Zhu L, Wang T, Perche F, Taigind A, Torchilin VP. Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety. Proceedings of the National Academy of Sciences of the United States of America. 110: 17047-52. PMID 24062440 DOI: 10.1073/Pnas.1304987110 |
0.489 |
|
| 2013 |
Patel NR, Pattni BS, Abouzeid AH, Torchilin VP. Nanopreparations to overcome multidrug resistance in cancer. Advanced Drug Delivery Reviews. 65: 1748-62. PMID 23973912 DOI: 10.1016/J.Addr.2013.08.004 |
0.806 |
|
| 2013 |
Deshpande PP, Biswas S, Torchilin VP. Current trends in the use of liposomes for tumor targeting. Nanomedicine (London, England). 8: 1509-28. PMID 23914966 DOI: 10.2217/Nnm.13.118 |
0.471 |
|
| 2013 |
Moussa M, Goldberg SN, Tasawwar B, Sawant RR, Levchenko T, Kumar G, Torchilin VP, Ahmed M. Adjuvant liposomal doxorubicin markedly affects radiofrequency ablation-induced effects on periablational microvasculature. Journal of Vascular and Interventional Radiology : Jvir. 24: 1021-33. PMID 23664809 DOI: 10.1016/J.Jvir.2013.03.006 |
0.39 |
|
| 2013 |
Torchilin VP. Interview with Vladimir P Torchilin: liposomal carriers for drug delivery. Therapeutic Delivery. 4: 537-8. PMID 23647271 DOI: 10.4155/Tde.13.25 |
0.365 |
|
| 2013 |
Sawant RR, Jhaveri AM, Koshkaryev A, Qureshi F, Torchilin VP. The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy. Journal of Drug Targeting. 21: 630-8. PMID 23594094 DOI: 10.3109/1061186X.2013.789032 |
0.46 |
|
| 2013 |
Perche F, Torchilin VP. Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting. Journal of Drug Delivery. 2013: 705265. PMID 23533772 DOI: 10.1155/2013/705265 |
0.421 |
|
| 2013 |
Riehle RD, Cornea S, Degterev A, Torchilin V. Micellar formulations of pro-apoptotic DM-PIT-1 analogs and TRAIL in vitro and in vivo. Drug Delivery. 20: 78-85. PMID 23495715 DOI: 10.3109/10717544.2013.766780 |
0.799 |
|
| 2013 |
Abouzeid AH, Torchilin VP. The role of cell cycle in the efficiency and activity of cancer nanomedicines. Expert Opinion On Drug Delivery. 10: 775-86. PMID 23441879 DOI: 10.1517/17425247.2013.776538 |
0.802 |
|
| 2013 |
Biswas S, Deshpande PP, Perche F, Dodwadkar NS, Sane SD, Torchilin VP. Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer. Cancer Letters. 335: 191-200. PMID 23419527 DOI: 10.1016/J.Canlet.2013.02.020 |
0.331 |
|
| 2013 |
Biswas S, Dodwadkar NS, Deshpande PP, Parab S, Torchilin VP. Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 84: 517-25. PMID 23333899 DOI: 10.1016/J.Ejpb.2012.12.021 |
0.352 |
|
| 2013 |
Musacchio T, Torchilin VP. siRNA delivery: from basics to therapeutic applications. Frontiers in Bioscience (Landmark Edition). 18: 58-79. PMID 23276909 DOI: 10.2741/4087 |
0.37 |
|
| 2013 |
Movassaghian S, Moghimi HR, Shirazi FH, Koshkaryev A, Trivedi MS, Torchilin VP. Efficient down-regulation of PKC-α gene expression in A549 lung cancer cells mediated by antisense oligodeoxynucleotides in dendrosomes. International Journal of Pharmaceutics. 441: 82-91. PMID 23262426 DOI: 10.1016/J.Ijpharm.2012.12.015 |
0.422 |
|
| 2013 |
Thekkedath R, Koshkaryev A, Torchilin VP. Lysosome-targeted octadecyl-rhodamine B-liposomes enhance lysosomal accumulation of glucocerebrosidase in Gaucher's cells in vitro. Nanomedicine (London, England). 8: 1055-65. PMID 23199221 DOI: 10.2217/Nnm.12.138 |
0.799 |
|
| 2013 |
Biswas S, Deshpande PP, Navarro G, Dodwadkar NS, Torchilin VP. Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery. Biomaterials. 34: 1289-301. PMID 23137395 DOI: 10.1016/J.Biomaterials.2012.10.024 |
0.385 |
|
| 2013 |
Wu H, Zhu L, Torchilin VP. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. Biomaterials. 34: 1213-22. PMID 23102622 DOI: 10.1016/J.Biomaterials.2012.08.072 |
0.432 |
|
| 2013 |
Silindir M, Erdoğan S, Özer AY, Doğan AL, Tuncel M, Uğur Ö, Torchilin VP. Nanosized multifunctional liposomes for tumor diagnosis and molecular imaging by SPECT/CT. Journal of Liposome Research. 23: 20-7. PMID 23078019 DOI: 10.3109/08982104.2012.722107 |
0.395 |
|
| 2013 |
Koshkaryev A, Sawant R, Deshpande M, Torchilin V. Immunoconjugates and long circulating systems: origins, current state of the art and future directions. Advanced Drug Delivery Reviews. 65: 24-35. PMID 22964425 DOI: 10.1016/J.Addr.2012.08.009 |
0.4 |
|
| 2013 |
Zhu L, Torchilin VP. Stimulus-responsive nanopreparations for tumor targeting. Integrative Biology : Quantitative Biosciences From Nano to Macro. 5: 96-107. PMID 22869005 DOI: 10.1039/C2Ib20135F |
0.451 |
|
| 2013 |
Koshkaryev A, Piroyan A, Torchilin VP. Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition. Cancer Letters. 334: 293-301. PMID 22743614 DOI: 10.1016/J.Canlet.2012.06.008 |
0.327 |
|
| 2013 |
Sawant RR, Patel NR, Torchilin VP. Therapeutic delivery using cell-penetrating peptides European Journal of Nanomedicine. 5. DOI: 10.1515/Ejnm-2013-0005 |
0.701 |
|
| 2012 |
Wang T, Petrenko VA, Torchilin VP. Optimization of Landscape Phage Fusion Protein-Modified Polymeric PEG-PE Micelles for Improved Breast Cancer Cell Targeting. Journal of Nanomedicine & Nanotechnology. 008. PMID 26451274 DOI: 10.4172/2157-7439.S4-008 |
0.428 |
|
| 2012 |
Torchilin V. NEXT STEP IN DRUG DELIVERY: GETTING TO INDIVIDUAL ORGANELLES. Drug Delivery and Translational Research. 2: 415-417. PMID 23565351 DOI: 10.1007/S13346-012-0102-2 |
0.513 |
|
| 2012 |
Shutava TG, Pattekari PP, Arapov KA, Torchilin VP, Lvov YM. Architectural layer-by-layer assembly of drug nanocapsules with PEGylated polyelectrolytes. Soft Matter. 8: 9418-9427. PMID 23144650 DOI: 10.1039/C2Sm25683E |
0.352 |
|
| 2012 |
Sarisozen C, Vural I, Levchenko T, Hincal AA, Torchilin VP. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance. Drug Delivery. 19: 363-70. PMID 23030458 DOI: 10.3109/10717544.2012.724473 |
0.378 |
|
| 2012 |
Perche F, Patel NR, Torchilin VP. Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model. Journal of Controlled Release : Official Journal of the Controlled Release Society. 164: 95-102. PMID 22974689 DOI: 10.1016/J.Jconrel.2012.09.003 |
0.743 |
|
| 2012 |
Sawant RR, Jhaveri AM, Torchilin VP. Immunomicelles for advancing personalized therapy. Advanced Drug Delivery Reviews. 64: 1436-46. PMID 22917778 DOI: 10.1016/J.Addr.2012.08.003 |
0.342 |
|
| 2012 |
Perche F, Torchilin VP. Cancer cell spheroids as a model to evaluate chemotherapy protocols. Cancer Biology & Therapy. 13: 1205-13. PMID 22892843 DOI: 10.4161/Cbt.21353 |
0.438 |
|
| 2012 |
Levchenko TS, Hartner WC, Torchilin VP. Liposomes in diagnosis and treatment of cardiovascular disorders. Methodist Debakey Cardiovascular Journal. 8: 36-41. PMID 22891109 DOI: 10.14797/Mdcj-8-1-36 |
0.405 |
|
| 2012 |
Levchenko TS, Hartner WC, Torchilin VP. Liposomes for cardiovascular targeting. Therapeutic Delivery. 3: 501-14. PMID 22834079 DOI: 10.4155/Tde.12.18 |
0.416 |
|
| 2012 |
Koren E, Torchilin VP. Cell-penetrating peptides: breaking through to the other side. Trends in Molecular Medicine. 18: 385-93. PMID 22682515 DOI: 10.1016/J.Molmed.2012.04.012 |
0.39 |
|
| 2012 |
Zamboni WC, Torchilin V, Patri AK, Hrkach J, Stern S, Lee R, Nel A, Panaro NJ, Grodzinski P. Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 3229-41. PMID 22669131 DOI: 10.1158/1078-0432.Ccr-11-2938 |
0.446 |
|
| 2012 |
Sarisozen C, Vural I, Levchenko T, Hincal AA, Torchilin VP. PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells. Drug Delivery. 19: 169-76. PMID 22506922 DOI: 10.3109/10717544.2012.674163 |
0.426 |
|
| 2012 |
Xing C, Levchenko T, Guo S, Stins M, Torchilin VP, Lo EH. Delivering minocycline into brain endothelial cells with liposome-based technology. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 983-8. PMID 22491155 DOI: 10.1038/Jcbfm.2012.48 |
0.313 |
|
| 2012 |
Biswas S, Dodwadkar NS, Piroyan A, Torchilin VP. Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria. Biomaterials. 33: 4773-82. PMID 22469294 DOI: 10.1016/J.Biomaterials.2012.03.032 |
0.389 |
|
| 2012 |
Sawant RR, Torchilin VP. Challenges in development of targeted liposomal therapeutics. The Aaps Journal. 14: 303-15. PMID 22415612 DOI: 10.1208/S12248-012-9330-0 |
0.472 |
|
| 2012 |
Zhu L, Kate P, Torchilin VP. Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. Acs Nano. 6: 3491-8. PMID 22409425 DOI: 10.1021/Nn300524F |
0.485 |
|
| 2012 |
Dao KL, Sawant RR, Hendricks JA, Ronga V, Torchilin VP, Hanson RN. Design, synthesis, and initial biological evaluation of a steroidal anti-estrogen-doxorubicin bioconjugate for targeting estrogen receptor-positive breast cancer cells. Bioconjugate Chemistry. 23: 785-95. PMID 22404783 DOI: 10.1021/Bc200645N |
0.353 |
|
| 2012 |
Chernenko T, Sawant RR, Miljkovic M, Quintero L, Diem M, Torchilin V. Raman microscopy for noninvasive imaging of pharmaceutical nanocarriers: intracellular distribution of cationic liposomes of different composition. Molecular Pharmaceutics. 9: 930-6. PMID 22376068 DOI: 10.1021/Mp200519Y |
0.429 |
|
| 2012 |
Sawant RR, Sriraman SK, Navarro G, Biswas S, Dalvi RA, Torchilin VP. Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery. Biomaterials. 33: 3942-51. PMID 22365809 DOI: 10.1016/J.Biomaterials.2011.11.088 |
0.385 |
|
| 2012 |
Koshkaryev A, Piroyan A, Torchilin VP. Increased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomes. Cancer Biology & Therapy. 13: 50-60. PMID 22336588 DOI: 10.4161/Cbt.13.1.18871 |
0.453 |
|
| 2012 |
Etzerodt A, Maniecki MB, Graversen JH, Møller HJ, Torchilin VP, Moestrup SK. Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163. Journal of Controlled Release : Official Journal of the Controlled Release Society. 160: 72-80. PMID 22306335 DOI: 10.1016/J.Jconrel.2012.01.034 |
0.321 |
|
| 2012 |
Biswas S, Dodwadkar NS, Deshpande PP, Torchilin VP. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. Journal of Controlled Release : Official Journal of the Controlled Release Society. 159: 393-402. PMID 22286008 DOI: 10.1016/J.Jconrel.2012.01.009 |
0.452 |
|
| 2012 |
Navarro G, Sawant RR, Biswas S, Essex S, Tros de Ilarduya C, Torchilin VP. P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells. Nanomedicine (London, England). 7: 65-78. PMID 22191778 DOI: 10.2217/Nnm.11.93 |
0.36 |
|
| 2012 |
Koren E, Apte A, Jani A, Torchilin VP. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity. Journal of Controlled Release : Official Journal of the Controlled Release Society. 160: 264-73. PMID 22182771 DOI: 10.1016/J.Jconrel.2011.12.002 |
0.805 |
|
| 2012 |
Miao B, Skidan I, Yang J, You Z, Fu X, Famulok M, Schaffhausen B, Torchilin V, Yuan J, Degterev A. Inhibition of cell migration by PITENINs: The role of ARF6 Oncogene. 31: 4317-4332. PMID 22179837 DOI: 10.1038/Onc.2011.593 |
0.347 |
|
| 2012 |
Buyens K, De Smedt SC, Braeckmans K, Demeester J, Peeters L, van Grunsven LA, de Mollerat du Jeu X, Sawant R, Torchilin V, Farkasova K, Ogris M, Sanders NN. Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design. Journal of Controlled Release : Official Journal of the Controlled Release Society. 158: 362-70. PMID 22023849 DOI: 10.1016/J.Jconrel.2011.10.009 |
0.357 |
|
| 2012 |
Sawant RR, Vaze OS, Wang T, D'Souza GG, Rockwell K, Gada K, Khaw BA, Torchilin VP. Palmitoyl ascorbate liposomes and free ascorbic acid: comparison of anticancer therapeutic effects upon parenteral administration. Pharmaceutical Research. 29: 375-83. PMID 21845505 DOI: 10.1007/S11095-011-0557-8 |
0.31 |
|
| 2012 |
Wang T, Upponi JR, Torchilin VP. Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies. International Journal of Pharmaceutics. 427: 3-20. PMID 21798324 DOI: 10.1016/J.Ijpharm.2011.07.013 |
0.312 |
|
| 2012 |
Whiteman KR, Subr V, Ulbrich K, Torchilin VP. Poly(Hpma)-coated liposomes demonstrate prolonged circulation in mice. Journal of Liposome Research. 11: 153-64. PMID 19530930 DOI: 10.1081/Lpr-100108459 |
0.38 |
|
| 2012 |
Shutava TG, Arapov KA, Pattekari PP, Lvov YM, Levchenko TS, Sawant RR, Torchilin VP. Stable Colloids of Paclitaxel Nanoparticles Coated with PEGylated Polyelectrolyte Shells Mrs Proceedings. 1416. DOI: 10.1557/Opl.2012.480 |
0.32 |
|
| 2012 |
Perche F, Torchilin VP. Abstract B49: Cancer cell spheroids as a model to study sequential chemotherapy protocols Clinical Cancer Research. 18: B49-B49. DOI: 10.1158/1078-0432.Mechres-B49 |
0.455 |
|
| 2012 |
Musacchio T, Navarro G, Torchilin V. Molecular assemblies for siRNA delivery Journal of Drug Delivery Science and Technology. 22: 5-16. DOI: 10.1016/S1773-2247(12)50001-8 |
0.363 |
|
| 2012 |
Sarisozen C, Vural I, Hincal AA, Torchilin VP. Reversal of multidrug resistance by antibody targeted micelles New Biotechnology. 29: S164-S165. DOI: 10.1016/J.Nbt.2012.08.457 |
0.316 |
|
| 2012 |
Sawant RR, Torchilin VP. Multifunctional nanocarriers and intracellular drug delivery Current Opinion in Solid State and Materials Science. 16: 269-275. DOI: 10.1016/J.Cossms.2012.09.001 |
0.42 |
|
| 2012 |
Torchilin VP. Multifunctional Pharmaceutical Nanocarriers: Promises and Problems Nanotechnologies For the Life Sciences. DOI: 10.1002/9783527610419.Ntls0249 |
0.382 |
|
| 2011 |
Navarro G, Sawant RR, Essex S, Tros de Ilarduya C, Torchilin VP. Phospholipid-polyethylenimine conjugate-based micelle-like nanoparticles for siRNA delivery. Drug Delivery and Translational Research. 1: 25-33. PMID 22916337 DOI: 10.1007/S13346-010-0004-0 |
0.436 |
|
| 2011 |
Movassaghian S, Moghimi HR, Shirazi FH, Torchilin VP. Dendrosome-dendriplex inside liposomes: as a gene delivery system. Journal of Drug Targeting. 19: 925-32. PMID 22023509 DOI: 10.3109/1061186X.2011.628396 |
0.379 |
|
| 2011 |
Meerovich I, Koshkaryev A, Thekkedath R, Torchilin VP. Screening and optimization of ligand conjugates for lysosomal targeting. Bioconjugate Chemistry. 22: 2271-82. PMID 21913714 DOI: 10.1021/Bc200336J |
0.812 |
|
| 2011 |
Biswas S, Dodwadkar NS, Sawant RR, Torchilin VP. Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization. Bioconjugate Chemistry. 22: 2005-13. PMID 21870873 DOI: 10.1021/Bc2002133 |
0.407 |
|
| 2011 |
Koren E, Torchilin VP. Drug carriers for vascular drug delivery. Iubmb Life. 63: 586-95. PMID 21766415 DOI: 10.1002/Iub.496 |
0.418 |
|
| 2011 |
Meerovich I, Koshkaryev A, Torchilin VP. Kinetic and thermodynamic approaches to the drug targeting phenomena. Current Drug Discovery Technologies. 8: 287-300. PMID 21726187 DOI: 10.2174/157016311798109335 |
0.46 |
|
| 2011 |
Patel NR, Rathi A, Mongayt D, Torchilin VP. Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes. International Journal of Pharmaceutics. 416: 296-9. PMID 21703341 DOI: 10.1016/J.Ijpharm.2011.05.082 |
0.688 |
|
| 2011 |
Wang T, Kulkarni N, D'Souza GG, Petrenko VA, Torchilin VP. On the mechanism of targeting of phage fusion protein-modified nanocarriers: only the binding peptide sequence matters. Molecular Pharmaceutics. 8: 1720-8. PMID 21675738 DOI: 10.1021/Mp200080H |
0.368 |
|
| 2011 |
Sawant RR, Torchilin VP. Design and synthesis of novel functional lipid-based bioconjugates for drug delivery and other applications. Methods in Molecular Biology (Clifton, N.J.). 751: 357-78. PMID 21674343 DOI: 10.1007/978-1-61779-151-2_23 |
0.387 |
|
| 2011 |
Skidan I, Grunwald J, Thekkedath R, Degterev A, Torchilin V. A HPLC method for the quantitative determination of N-(2-hydroxy-5-nitrophenylcarbamothioyl)-3,5-dimethylbenzamide in biological samples. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 879: 1610-6. PMID 21514904 DOI: 10.1016/J.Jchromb.2011.03.055 |
0.773 |
|
| 2011 |
Pattekari P, Zheng Z, Zhang X, Levchenko T, Torchilin V, Lvov Y. Top-down and bottom-up approaches in production of aqueous nanocolloids of low solubility drug paclitaxel. Physical Chemistry Chemical Physics : Pccp. 13: 9014-9. PMID 21442095 DOI: 10.1039/C0Cp02549F |
0.368 |
|
| 2011 |
Koren E, Apte A, Sawant RR, Grunwald J, Torchilin VP. Cell-penetrating TAT peptide in drug delivery systems: proteolytic stability requirements. Drug Delivery. 18: 377-84. PMID 21438724 DOI: 10.3109/10717544.2011.567310 |
0.809 |
|
| 2011 |
Biswas S, Dodwadkar NS, Sawant RR, Koshkaryev A, Torchilin VP. Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting. Journal of Drug Targeting. 19: 552-61. PMID 21348804 DOI: 10.3109/1061186X.2010.536983 |
0.448 |
|
| 2011 |
Koshkaryev A, Thekkedath R, Pagano C, Meerovich I, Torchilin VP. Targeting of lysosomes by liposomes modified with octadecyl-rhodamine B Journal of Drug Targeting. 19: 606-614. PMID 21275828 DOI: 10.3109/1061186X.2010.550921 |
0.812 |
|
| 2011 |
Wang T, Kulkarni N, Bedi D, D'Souza GG, Papahadjopoulos-Sternberg B, Petrenko VA, Torchilin VP. In vitro optimization of liposomal nanocarriers prepared from breast tumor cell specific phage fusion protein. Journal of Drug Targeting. 19: 597-605. PMID 21275826 DOI: 10.3109/1061186X.2010.550920 |
0.427 |
|
| 2011 |
Musacchio T, Torchilin VP. Recent developments in lipid-based pharmaceutical nanocarriers. Frontiers in Bioscience (Landmark Edition). 16: 1388-412. PMID 21196238 DOI: 10.2741/3795 |
0.436 |
|
| 2011 |
Sawant R, Torchilin V. Intracellular delivery of nanoparticles with CPPs. Methods in Molecular Biology (Clifton, N.J.). 683: 431-51. PMID 21053148 DOI: 10.1007/978-1-60761-919-2_31 |
0.41 |
|
| 2011 |
Bedi D, Musacchio T, Fagbohun OA, Gillespie JW, Deinnocentes P, Bird RC, Bookbinder L, Torchilin VP, Petrenko VA. Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes. Nanomedicine : Nanotechnology, Biology, and Medicine. 7: 315-23. PMID 21050894 DOI: 10.1016/J.Nano.2010.10.004 |
0.441 |
|
| 2011 |
Sawant RR, Vaze O, D'Souza GG, Rockwell K, Torchilin VP. Palmitoyl ascorbate-loaded polymeric micelles: cancer cell targeting and cytotoxicity. Pharmaceutical Research. 28: 301-8. PMID 20730558 DOI: 10.1007/S11095-010-0242-3 |
0.435 |
|
| 2011 |
Serda RE, Blanco E, Mack A, Stafford SJ, Amra S, Li Q, van de Ven A, Tanaka T, Torchilin VP, Wiktorowicz JE, Ferrari M. Proteomic Analysis of Serum Opsonins Impacting Biodistribution and Cellular Association of Porous Silicon Microparticles Molecular Imaging. 10: 7290.2011.00008. DOI: 10.2310/7290.2011.00008 |
0.329 |
|
| 2010 |
Torchilin VP. Antinuclear antibodies with nucleosome-restricted specificity for targeted delivery of chemotherapeutic agents. Therapeutic Delivery. 1: 257-72. PMID 22816132 DOI: 10.4155/Tde.10.30 |
0.438 |
|
| 2010 |
Lvov YM, Pattekari P, Zhang X, Torchilin V. Converting poorly soluble materials into stable aqueous nanocolloids. Langmuir : the Acs Journal of Surfaces and Colloids. 27: 1212-7. PMID 21190345 DOI: 10.1021/La1041635 |
0.31 |
|
| 2010 |
Papagiannaros A, Upponi J, Hartner W, Mongayt D, Levchenko T, Torchilin V. Quantum dot loaded immunomicelles for tumor imaging. Bmc Medical Imaging. 10: 22. PMID 20955559 DOI: 10.1186/1471-2342-10-22 |
0.346 |
|
| 2010 |
Sawant RR, Torchilin VP. Multifunctionality of lipid-core micelles for drug delivery and tumour targeting. Molecular Membrane Biology. 27: 232-46. PMID 20929339 DOI: 10.3109/09687688.2010.516276 |
0.476 |
|
| 2010 |
Yang W, Ahmed M, Elian M, Hady el-SA, Levchenko TS, Sawant RR, Signoretti S, Collins M, Torchilin VP, Goldberg SN. Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model? Radiology. 257: 685-96. PMID 20858851 DOI: 10.1148/Radiol.10100500 |
0.34 |
|
| 2010 |
Musacchio T, Vaze O, D'Souza G, Torchilin VP. Effective stabilization and delivery of siRNA: reversible siRNA-phospholipid conjugate in nanosized mixed polymeric micelles. Bioconjugate Chemistry. 21: 1530-6. PMID 20669936 DOI: 10.1021/Bc100199C |
0.417 |
|
| 2010 |
Wang T, D'Souza GG, Bedi D, Fagbohun OA, Potturi LP, Papahadjopoulos-Sternberg B, Petrenko VA, Torchilin VP. Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein. Nanomedicine (London, England). 5: 563-74. PMID 20528452 DOI: 10.2217/Nnm.10.30 |
0.46 |
|
| 2010 |
Wang T, Petrenko VA, Torchilin VP. Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity. Molecular Pharmaceutics. 7: 1007-14. PMID 20518562 DOI: 10.1021/Mp1001125 |
0.496 |
|
| 2010 |
Wang T, Yang S, Petrenko VA, Torchilin VP. Cytoplasmic delivery of liposomes into MCF-7 breast cancer cells mediated by cell-specific phage fusion coat protein. Molecular Pharmaceutics. 7: 1149-58. PMID 20438086 DOI: 10.1021/Mp1000229 |
0.461 |
|
| 2010 |
Sawant RR, Vaze OS, Rockwell K, Torchilin VP. Palmitoyl ascorbate-modified liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 75: 321-6. PMID 20433922 DOI: 10.1016/J.Ejpb.2010.04.010 |
0.428 |
|
| 2010 |
Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Advanced Drug Delivery Reviews. 63: 131-5. PMID 20304019 DOI: 10.1016/J.Addr.2010.03.011 |
0.422 |
|
| 2010 |
Sawant RR, Torchilin VP. Polymeric micelles: polyethylene glycol-phosphatidylethanolamine (PEG-PE)-based micelles as an example. Methods in Molecular Biology (Clifton, N.J.). 624: 131-49. PMID 20217593 DOI: 10.1007/978-1-60761-609-2_9 |
0.433 |
|
| 2010 |
Torchilin VP. Passive and active drug targeting: drug delivery to tumors as an example. Handbook of Experimental Pharmacology. 3-53. PMID 20217525 DOI: 10.1007/978-3-642-00477-3_1 |
0.447 |
|
| 2010 |
Jayanna PK, Bedi D, Gillespie JW, DeInnocentes P, Wang T, Torchilin VP, Bird RC, Petrenko VA. Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency. Nanomedicine : Nanotechnology, Biology, and Medicine. 6: 538-46. PMID 20138246 DOI: 10.1016/J.Nano.2010.01.005 |
0.419 |
|
| 2010 |
Levchenko TS, Hartner WC, Verma DD, Bernstein EA, Torchilin VP. ATP-loaded liposomes for targeted treatment in models of myocardial ischemia. Methods in Molecular Biology (Clifton, N.J.). 605: 361-75. PMID 20072894 DOI: 10.1007/978-1-60327-360-2_25 |
0.335 |
|
| 2010 |
Erdogan S, Torchilin VP. Gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes Methods in Molecular Biology (Clifton, N.J.). 605: 321-334. PMID 20072891 DOI: 10.1007/978-1-60327-360-2_22 |
0.307 |
|
| 2010 |
Kale AA, Torchilin VP. Environment-responsive multifunctional liposomes. Methods in Molecular Biology (Clifton, N.J.). 605: 213-42. PMID 20072884 DOI: 10.1007/978-1-60327-360-2_15 |
0.436 |
|
| 2010 |
Elbayoumi TA, Torchilin VP. Current trends in liposome research. Methods in Molecular Biology (Clifton, N.J.). 605: 1-27. PMID 20072870 DOI: 10.1007/978-1-60327-360-2_1 |
0.375 |
|
| 2010 |
Salmaso S, Pappalardo JS, Sawant RR, Musacchio T, Rockwell K, Caliceti P, Torchilin VP. Targeting glioma cells in vitro with ascorbate-conjugated pharmaceutical nanocarriers. Bioconjugate Chemistry. 20: 2348-55. PMID 19928843 DOI: 10.1021/Bc900369D |
0.416 |
|
| 2010 |
Patel NR, Hatziantoniou S, Georgopoulos A, Demetzos C, Torchilin VP, Weissig V, D'Souza GG. Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol. Journal of Liposome Research. 20: 244-9. PMID 19883213 DOI: 10.3109/08982100903347931 |
0.716 |
|
| 2010 |
Sawant RR, Torchilin VP. Liposomes as ‘smart’ pharmaceutical nanocarriers Soft Matter. 6: 4026. DOI: 10.1039/B923535N |
0.304 |
|
| 2009 |
Kale AA, Torchilin VP. Environment-Responsive Polymers for Coating of Pharmaceutical Nanocarriers(,). Polymer Science. Series a, Chemistry, Physics. 51: 730-737. PMID 23150741 DOI: 10.1134/S0965545X09060182 |
0.356 |
|
| 2009 |
Veerabadran NG, Mongayt D, Torchilin V, Price RR, Lvov YM. Organized shells on clay nanotubes for controlled release of macromolecules. Macromolecular Rapid Communications. 30: 99-103. PMID 21706582 DOI: 10.1002/Marc.200800510 |
0.335 |
|
| 2009 |
Sawant R, Torchilin V. Intracellular transduction using cell-penetrating peptides. Molecular Biosystems. 6: 628-40. PMID 20237640 DOI: 10.1039/B916297F |
0.333 |
|
| 2009 |
Hartner WC, Verma DD, Levchenko TS, Bernstein EA, Torchilin VP. ATP-loaded liposomes for treatment of myocardial ischemia. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 1: 530-9. PMID 20049815 DOI: 10.1002/Wnan.46 |
0.339 |
|
| 2009 |
Musacchio T, Toniutti M, Kautz R, Torchilin VP. 1H NMR detection of mobile lipids as a marker for apoptosis: The case of anticancer drug-loaded liposomes and polymeric micelles Molecular Pharmaceutics. 6: 1876-1882. PMID 19737025 DOI: 10.1021/mp900164n |
0.319 |
|
| 2009 |
Musacchio T, Laquintana V, Latrofa A, Trapani G, Torchilin VP. PEG-PE micelles loaded with paclitaxel and surface-modified by a PBR-ligand: synergistic anticancer effect. Molecular Pharmaceutics. 6: 468-79. PMID 19718800 DOI: 10.1021/Mp800158C |
0.5 |
|
| 2009 |
LaBeaume P, Wager K, Falcone D, Li J, Torchilin V, Castro C, Holewa C, Kallmerten AE, Jones GB. Synthesis, functionalization and photo-Bergman chemistry of enediyne bioconjugates. Bioorganic & Medicinal Chemistry. 17: 6292-300. PMID 19665388 DOI: 10.1016/J.Bmc.2009.07.059 |
0.307 |
|
| 2009 |
Grunwald J, Rejtar T, Sawant R, Wang Z, Torchilin VP. TAT peptide and its conjugates: proteolytic stability. Bioconjugate Chemistry. 20: 1531-7. PMID 19601640 DOI: 10.1021/Bc900081E |
0.35 |
|
| 2009 |
Skidan I, Miao B, Thekkedath RV, Dholakia P, Degterev A, Torchilin V. In vitro cytotoxicity of novel pro-apoptotic agent DM-PIT-1 in PEG-PE-based micelles alone and in combination with TRAIL. Drug Delivery. 16: 45-51. PMID 19555308 DOI: 10.1080/10717540802517951 |
0.82 |
|
| 2009 |
Sawant RR, Torchilin VP. Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo. International Journal of Pharmaceutics. 374: 114-8. PMID 19446767 DOI: 10.1016/J.Ijpharm.2009.02.022 |
0.443 |
|
| 2009 |
Young TK, Falcao C, Torchilin VP. Cationic liposomes loaded with proapoptotic peptide D-(KLAKLAK)2 and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced anticancer therapy Molecular Pharmaceutics. 6: 971-977. PMID 19317442 DOI: 10.1021/Mp900006H |
0.794 |
|
| 2009 |
ElBayoumi TA, Torchilin VP. Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1973-80. PMID 19276264 DOI: 10.1158/1078-0432.Ccr-08-2392 |
0.5 |
|
| 2009 |
Pappalardo JS, Quattrocchi V, Langellotti C, Di Giacomo S, Gnazzo V, Olivera V, Calamante G, Zamorano PI, Levchenko TS, Torchilin VP. Improved transfection of spleen-derived antigen-presenting cells in culture using TATp-liposomes Journal of Controlled Release. 134: 41-46. PMID 19059290 DOI: 10.1016/J.Jconrel.2008.11.006 |
0.345 |
|
| 2009 |
Elbayoumi TA, Torchilin VP. Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice. Molecular Pharmaceutics. 6: 246-54. PMID 19049322 DOI: 10.1021/Mp8001528 |
0.43 |
|
| 2009 |
Elbayoumi TA, Torchilin VP. Liposomes for targeted delivery of antithrombotic drugs. Expert Opinion On Drug Delivery. 5: 1185-98. PMID 18976130 DOI: 10.1517/17425240802497457 |
0.424 |
|
| 2009 |
Ko YT, Kale A, Hartner WC, Papahadjopoulos-Sternberg B, Torchilin VP. Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 133: 132-8. PMID 18929605 DOI: 10.1016/J.Jconrel.2008.09.079 |
0.371 |
|
| 2009 |
Jayanna PK, Torchilin VP, Petrenko VA. Liposomes targeted by fusion phage proteins. Nanomedicine : Nanotechnology, Biology, and Medicine. 5: 83-9. PMID 18838343 DOI: 10.1016/J.Nano.2008.07.006 |
0.368 |
|
| 2009 |
Ko YT, Hartner WC, Kale A, Torchilin VP. Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide. Gene Therapy. 16: 52-9. PMID 18701915 DOI: 10.1038/Gt.2008.135 |
0.377 |
|
| 2009 |
Papagiannaros A, Kale A, Levchenko TS, Mongayt D, Hartner WC, Torchilin VP. Near infrared planar tumor imaging and quantification using nanosized Alexa 750-labeled phospholipid micelles. International Journal of Nanomedicine. 4: 123-131. DOI: 10.2147/Ijn.S5520 |
0.31 |
|
| 2009 |
Sawant RM, Sawant RR, Gultepe E, Nagesha D, Papahadjopoulos-Sternberg B, Sridhar S, Torchilin VP. Nanosized cancer cell-targeted polymeric immunomicelles loaded with superparamagnetic iron oxide nanoparticles Journal of Nanoparticle Research. 11: 1777-1785. DOI: 10.1007/S11051-009-9611-4 |
0.786 |
|
| 2008 |
Torchilin V. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 71: 431-44. PMID 18977297 DOI: 10.1016/J.Ejpb.2008.09.026 |
0.378 |
|
| 2008 |
Torchilin V. Antibody-modified liposomes for cancer chemotherapy. Expert Opinion On Drug Delivery. 5: 1003-25. PMID 18754750 DOI: 10.1517/17425247.5.9.1003 |
0.44 |
|
| 2008 |
Sawant RM, Cohen MB, Torchilin VP, Rokhlin OW. Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro. Journal of Drug Targeting. 16: 601-4. PMID 18686131 DOI: 10.1080/10611860802228954 |
0.766 |
|
| 2008 |
Sawant RR, Sawant RM, Kale AA, Torchilin VP. The architecture of ligand attachment to nanocarriers controls their specific interaction with target cells. Journal of Drug Targeting. 16: 596-600. PMID 18686130 DOI: 10.1080/10611860802230240 |
0.77 |
|
| 2008 |
Torchilin VP. Preface. Fifth International Nanomedicine and Drug Delivery Symposium (NanoDDS'07). Journal of Controlled Release : Official Journal of the Controlled Release Society. 130: 97. PMID 18634838 DOI: 10.1016/J.Jconrel.2008.07.008 |
0.379 |
|
| 2008 |
D'Souza GG, Wang T, Rockwell K, Torchilin VP. Surface modification of pharmaceutical nanocarriers with ascorbate residues improves their tumor-cell association and killing and the cytotoxic action of encapsulated paclitaxel in vitro. Pharmaceutical Research. 25: 2567-72. PMID 18618230 DOI: 10.1007/S11095-008-9674-4 |
0.403 |
|
| 2008 |
Boddapati SV, D'Souza GG, Erdogan S, Torchilin VP, Weissig V. Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo. Nano Letters. 8: 2559-63. PMID 18611058 DOI: 10.1021/Nl801908Y |
0.456 |
|
| 2008 |
Skidan I, Dholakia P, Torchilin V. Photodynamic therapy of experimental B-16 melanoma in mice with tumor-targeted 5,10,15,20-tetraphenylporphin-loaded PEG-PE micelles. Journal of Drug Targeting. 16: 486-93. PMID 18604661 DOI: 10.1080/10611860802102175 |
0.458 |
|
| 2008 |
Sawant RR, Sawant RM, Torchilin VP. Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 70: 51-7. PMID 18583114 DOI: 10.1016/J.Ejpb.2008.04.016 |
0.805 |
|
| 2008 |
Agarwal A, Lvov Y, Sawant R, Torchilin V. Stable nanocolloids of poorly soluble drugs with high drug content prepared using the combination of sonication and layer-by-layer technology. Journal of Controlled Release : Official Journal of the Controlled Release Society. 128: 255-60. PMID 18479772 DOI: 10.1016/J.Jconrel.2008.03.017 |
0.77 |
|
| 2008 |
Torchilin VP. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers. 90: 604-10. PMID 18381624 DOI: 10.1002/Bip.20989 |
0.439 |
|
| 2008 |
Ljubimova JY, Fujita M, Ljubimov AV, Torchilin VP, Black KL, Holler E. Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery. Nanomedicine (London, England). 3: 247-65. PMID 18373429 DOI: 10.2217/17435889.3.2.247 |
0.448 |
|
| 2008 |
Elbayoumi TA, Torchilin VP. Tumor-specific antibody-mediated targeted delivery of Doxil reduces the manifestation of auricular erythema side effect in mice. International Journal of Pharmaceutics. 357: 272-9. PMID 18329201 DOI: 10.1016/J.Ijpharm.2008.01.041 |
0.422 |
|
| 2008 |
Erdogan S, Medarova ZO, Roby A, Moore A, Torchilin VP. Enhanced tumor MR imaging with gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes. Journal of Magnetic Resonance Imaging : Jmri. 27: 574-80. PMID 18219628 DOI: 10.1002/Jmri.21202 |
0.41 |
|
| 2008 |
Matthäus C, Kale A, Chernenko T, Torchilin V, Diem M. New ways of imaging uptake and intracellular fate of liposomal drug carrier systems inside individual cells, based on Raman microscopy. Molecular Pharmaceutics. 5: 287-93. PMID 18197626 DOI: 10.1021/Mp7001158 |
0.378 |
|
| 2008 |
Elbayoumi TA, Torchilin VP. Tumor-Targeted Immuno-liposomes for Delivery of Chemotherapeutics and Diagnostics Journal of Pharmaceutical Innovation. 3: 51-58. DOI: 10.1007/S12247-008-9021-7 |
0.439 |
|
| 2007 |
Torchilin VP. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Advanced Drug Delivery Reviews. 60: 548-58. PMID 18053612 DOI: 10.1016/J.Addr.2007.10.008 |
0.431 |
|
| 2007 |
Kale AA, Torchilin VP. "Smart" drug carriers: PEGylated TATp-modified pH-sensitive liposomes. Journal of Liposome Research. 17: 197-203. PMID 18027240 DOI: 10.1080/08982100701525035 |
0.465 |
|
| 2007 |
Gupta B, Levchenko TS, Torchilin VP. TAT peptide-modified liposomes provide enhanced gene delivery to intracranial human brain tumor xenografts in nude mice. Oncology Research. 16: 351-9. PMID 17913043 DOI: 10.3727/000000006783980946 |
0.374 |
|
| 2007 |
Elbayoumi TA, Torchilin VP. Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 32: 159-68. PMID 17707615 DOI: 10.1016/J.Ejps.2007.05.113 |
0.447 |
|
| 2007 |
Kale AA, Torchilin VP. Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes. Journal of Drug Targeting. 15: 538-45. PMID 17671900 DOI: 10.1080/10611860701498203 |
0.438 |
|
| 2007 |
Torchilin VP. Tatp-mediated intracellular delivery of pharmaceutical nanocarriers. Biochemical Society Transactions. 35: 816-20. PMID 17635155 DOI: 10.1042/Bst0350816 |
0.427 |
|
| 2007 |
Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. The Aaps Journal. 9: E128-47. PMID 17614355 DOI: 10.1208/Aapsj0902015 |
0.458 |
|
| 2007 |
Roby A, Erdogan S, Torchilin VP. Enhanced in vivo antitumor efficacy of poorly soluble PDT agent, meso-tetraphenylporphine, in PEG-PE-based tumor-targeted immunomicelles Cancer Biology and Therapy. 6: 1136-1142. PMID 17611407 DOI: 10.4161/Cbt.6.7.4345 |
0.402 |
|
| 2007 |
Elbayoumi TA, Pabba S, Roby A, Torchilin VP. Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents. Journal of Liposome Research. 17: 1-14. PMID 17454399 DOI: 10.1080/08982100601186474 |
0.471 |
|
| 2007 |
Kale AA, Torchilin VP. Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: the effect of substitutes at the hydrazone linkage on the ph stability of PEG-PE conjugates. Bioconjugate Chemistry. 18: 363-70. PMID 17309227 DOI: 10.1021/Bc060228X |
0.323 |
|
| 2007 |
Gupta B, Torchilin VP. Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice. Cancer Immunology, Immunotherapy : Cii. 56: 1215-23. PMID 17219149 DOI: 10.1007/S00262-006-0273-0 |
0.387 |
|
| 2007 |
Li L, Mu L, Torchilin V. Mixed micelles made of Pluronic and PEG-PE for solubilization of poorly soluble anticancer drug paclitaxel Journal of Drug Delivery Science and Technology. 17: 389-392. DOI: 10.1016/S1773-2247(07)50078-X |
0.434 |
|
| 2007 |
Kuskov AN, Shtilman MI, Goryachaya AV, Tashmuhamedov RI, Yaroslavov AA, Torchilin VP, Tsatsakis AM, Rizos AK. Self-assembling nanoscaled drug delivery systems composed of amphiphilic poly-N-vinylpyrrolidones Journal of Non-Crystalline Solids. 353: 3969-3975. DOI: 10.1016/J.Jnoncrysol.2007.02.061 |
0.332 |
|
| 2006 |
Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharmaceutical Research. 24: 1-16. PMID 17109211 DOI: 10.1007/S11095-006-9132-0 |
0.451 |
|
| 2006 |
Torchilin VP. Multifunctional nanocarriers. Advanced Drug Delivery Reviews. 58: 1532-55. PMID 17092599 DOI: 10.1016/j.addr.2006.09.009 |
0.319 |
|
| 2006 |
Erdogan S, Roby A, Torchilin VP. Enhanced tumor visualization by γ-scintigraphy with 111In-labeled polychelating-polymer-containing immunoliposomes Molecular Pharmaceutics. 3: 525-530. PMID 17009851 DOI: 10.1021/Mp060055T |
0.397 |
|
| 2006 |
Sawant RM, Hurley JP, Salmaso S, Kale A, Tolcheva E, Levchenko TS, Torchilin VP. "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjugate Chemistry. 17: 943-9. PMID 16848401 DOI: 10.1021/Bc060080H |
0.779 |
|
| 2006 |
Torchilin VP. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annual Review of Biomedical Engineering. 8: 343-75. PMID 16834560 DOI: 10.1146/Annurev.Bioeng.8.061505.095735 |
0.429 |
|
| 2006 |
Elbayoumi TA, Torchilin VP. Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies. European Journal of Nuclear Medicine and Molecular Imaging. 33: 1196-205. PMID 16763815 DOI: 10.1007/S00259-006-0139-X |
0.39 |
|
| 2006 |
Dabholkar RD, Sawant RM, Mongayt DA, Devarajan PV, Torchilin VP. Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. International Journal of Pharmaceutics. 315: 148-57. PMID 16616818 DOI: 10.1016/J.Ijpharm.2006.02.018 |
0.784 |
|
| 2006 |
Erdogan S, Roby A, Sawant R, Hurley J, Torchilin VP. Gadolinium-loaded polychelating polymer-containing cancer cell-specific immunoliposomes. Journal of Liposome Research. 16: 45-55. PMID 16556549 DOI: 10.1080/08982100500528784 |
0.792 |
|
| 2006 |
Zhang C, Tang N, Liu X, Liang W, Xu W, Torchilin VP. siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene. Journal of Controlled Release : Official Journal of the Controlled Release Society. 112: 229-39. PMID 16545478 DOI: 10.1016/J.Jconrel.2006.01.022 |
0.388 |
|
| 2006 |
Gupta B, Torchilin VP. Transactivating transcriptional activator-mediated drug delivery. Expert Opinion On Drug Delivery. 3: 177-90. PMID 16506946 DOI: 10.1517/17425247.3.2.177 |
0.383 |
|
| 2006 |
Roby A, Erdogan S, Torchilin VP. Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro European Journal of Pharmaceutics and Biopharmaceutics. 62: 235-240. PMID 16326084 DOI: 10.1016/J.Ejpb.2005.09.010 |
0.495 |
|
| 2005 |
Torchilin VP. Lipid-core micelles for targeted drug delivery. Current Drug Delivery. 2: 319-27. PMID 16305435 DOI: 10.2174/156720105774370221 |
0.465 |
|
| 2005 |
Gupta B, Levchenko TS, Mongayt DA, Torchilin VP. Monoclonal antibody 2C5-mediated binding of liposomes to brain tumor cells in vitro and in subcutaneous tumor model in vivo. Journal of Drug Targeting. 13: 337-43. PMID 16278153 DOI: 10.1080/10611860500286239 |
0.35 |
|
| 2005 |
Mu L, Elbayoumi TA, Torchilin VP. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. International Journal of Pharmaceutics. 306: 142-9. PMID 16242875 DOI: 10.1016/J.IJPHARM.2005.08.026 |
0.327 |
|
| 2005 |
Ahmed M, Lukyanov AN, Torchilin V, Tournier H, Schneider AN, Goldberg SN. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time. Journal of Vascular and Interventional Radiology : Jvir. 16: 1365-71. PMID 16221908 DOI: 10.1097/01.Rvi.0000175324.63304.25 |
0.368 |
|
| 2005 |
Leevy WM, Gammon ST, Levchenko T, Daranciang DD, Murillo O, Torchilin V, Piwnica-Worms D, Huettner JE, Gokel GW. Structure-activity relationships, kinetics, selectivity, and mechanistic studies of synthetic hydraphile channels in bacterial and mammalian cells. Organic & Biomolecular Chemistry. 3: 3544-50. PMID 16172693 DOI: 10.1039/B508157B |
0.304 |
|
| 2005 |
Stroh M, Zimmer JP, Duda DG, Levchenko TS, Cohen KS, Brown EB, Scadden DT, Torchilin VP, Bawendi MG, Fukumura D, Jain RK. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nature Medicine. 11: 678-82. PMID 15880117 DOI: 10.1038/Nm1247 |
0.314 |
|
| 2005 |
Ahmed M, Liu Z, Lukyanov AN, Signoretti S, Horkan C, Monsky WL, Torchilin VP, Goldberg SN. Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals. Radiology. 235: 469-77. PMID 15858089 DOI: 10.1148/Radiol.2352031856 |
0.369 |
|
| 2005 |
Wang J, Mongayt D, Torchilin VP. Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids. Journal of Drug Targeting. 13: 73-80. PMID 15848957 DOI: 10.1080/10611860400011935 |
0.445 |
|
| 2005 |
Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nature Reviews. Drug Discovery. 4: 145-60. PMID 15688077 DOI: 10.1038/Nrd1632 |
0.365 |
|
| 2005 |
Torchilin VP. Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate. Advanced Drug Delivery Reviews. 57: 95-109. PMID 15518923 DOI: 10.1016/J.Addr.2004.06.002 |
0.469 |
|
| 2005 |
Lukyanov AN, Elbayoumi TA, Chakilam AR, Torchilin VP. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. Journal of Controlled Release : Official Journal of the Controlled Release Society. 100: 135-44. PMID 15491817 DOI: 10.1016/J.Jconrel.2004.08.007 |
0.453 |
|
| 2005 |
Torchilin VP. Block copolymer micelles as a solution for drug delivery problems Expert Opinion On Therapeutic Patents. 15: 63-75. DOI: 10.1517/13543776.15.1.63 |
0.481 |
|
| 2005 |
Mu L, Chrastina A, Levchenko T, Torchilin VP. Micelles from Poly(ethylene glycol)–Phosphatidyl Ethanolamine Conjugates (Peg-Pe) as Pharmaceutical Nanocarriers for Poorly Soluble Drug Camptothecin Journal of Biomedical Nanotechnology. 1: 190-195. DOI: 10.1166/Jbn.2005.030 |
0.41 |
|
| 2005 |
Cheng S, Pabba S, Torchilin V, Fowle W, Kimpfler A, Schubert R, Weissig V. Towards mitochondria-specific delivery of apoptosis-inducing agents: DQAsomal incorporated paclitaxel Journal of Drug Delivery Science and Technology. 15: 81-86. DOI: 10.1016/S1773-2247(05)50010-8 |
0.46 |
|
| 2005 |
TORCHILIN V. Protein- and peptide-mediated transduction: mechanisms and implications for drug delivery Advanced Drug Delivery Reviews. 57: 489-490. DOI: 10.1016/J.Addr.2004.11.001 |
0.347 |
|
| 2004 |
Liang W, Levchenko T, Khaw BA, Torchilin V. ATP-containing immunoliposomes specific for cardiac myosin. Current Drug Delivery. 1: 1-7. PMID 16305365 DOI: 10.2174/1567201043480063 |
0.36 |
|
| 2004 |
Gupta B, Levchenko TS, Torchilin VP. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Advanced Drug Delivery Reviews. 57: 637-51. PMID 15722168 DOI: 10.1016/J.Addr.2004.10.007 |
0.392 |
|
| 2004 |
Torchilin VP. Targeted polymeric micelles for delivery of poorly soluble drugs. Cellular and Molecular Life Sciences : Cmls. 61: 2549-59. PMID 15526161 DOI: 10.1007/S00018-004-4153-5 |
0.49 |
|
| 2004 |
Lukyanov AN, Sawant RM, Hartner WC, Torchilin VP. PEGylated dextran as long-circulating pharmaceutical carrier. Journal of Biomaterials Science. Polymer Edition. 15: 621-30. PMID 15264663 DOI: 10.1163/156856204323046889 |
0.751 |
|
| 2004 |
Lukyanov AN, Torchilin VP. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Advanced Drug Delivery Reviews. 56: 1273-89. PMID 15109769 DOI: 10.1016/J.Addr.2003.12.004 |
0.443 |
|
| 2004 |
Wang J, Mongayt DA, Lukyanov AN, Levchenko TS, Torchilin VP. Preparation and in vitro synergistic anticancer effect of vitamin K3 and 1,8-diazabicyclo[5,4,0]undec-7-ene in poly(ethylene glycol)-diacyllipid micelles. International Journal of Pharmaceutics. 272: 129-35. PMID 15019076 DOI: 10.1016/J.Ijpharm.2003.12.011 |
0.44 |
|
| 2004 |
Lukyanov AN, Hartner WC, Torchilin VP. Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits. Journal of Controlled Release : Official Journal of the Controlled Release Society. 94: 187-93. PMID 14684282 DOI: 10.1016/J.Jconrel.2003.10.008 |
0.318 |
|
| 2004 |
Lizano C, Weissig V, Torchilin VP, Sancho P, García-Pérez AI, Pinilla M. In vivo biodistribution of erythrocytes and polyethyleneglycol-phosphatidylethanolamine micelles carrying the antitumour agent dequalinium. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 56: 153-7. PMID 12957627 DOI: 10.1016/S0939-6411(03)00089-4 |
0.403 |
|
| 2004 |
Torchilin VP. Cellular Drug Delivery, D. Robert Lu, Svein Øie (Eds.). Humana Press, Totowa, NJ (2004), 376 pp. Journal of Controlled Release. 99: 339-340. DOI: 10.1016/J.Jconrel.2004.07.011 |
0.354 |
|
| 2003 |
Levchenko TS, Rammohan R, Volodina N, Torchilin VP. Tat peptide-mediated intracellular delivery of liposomes. Methods in Enzymology. 372: 339-49. PMID 14610822 DOI: 10.1016/S0076-6879(03)72019-9 |
0.385 |
|
| 2003 |
D'Souza GG, Rammohan R, Cheng SM, Torchilin VP, Weissig V. DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells. Journal of Controlled Release : Official Journal of the Controlled Release Society. 92: 189-97. PMID 14499196 DOI: 10.1016/S0168-3659(03)00297-9 |
0.323 |
|
| 2003 |
Lukyanov AN, Gao Z, Torchilin VP. Micelles from polyethylene glycol/phosphatidylethanolamine conjugates for tumor drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 91: 97-102. PMID 12932641 DOI: 10.1016/S0168-3659(03)00217-7 |
0.417 |
|
| 2003 |
Gao Z, Lukyanov AN, Chakilam AR, Torchilin VP. PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing. Journal of Drug Targeting. 11: 87-92. PMID 12881194 DOI: 10.1080/1061186031000138623 |
0.441 |
|
| 2003 |
Torchilin VP, Lukyanov AN, Gao Z, Papahadjopoulos-Sternberg B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proceedings of the National Academy of Sciences of the United States of America. 100: 6039-44. PMID 12716967 DOI: 10.1073/Pnas.0931428100 |
0.479 |
|
| 2003 |
Torchilin VP, Lukyanov AN. Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discovery Today. 8: 259-66. PMID 12623240 DOI: 10.1016/S1359-6446(03)02623-0 |
0.428 |
|
| 2003 |
Torchilin VP, Levchenko TS, Rammohan R, Volodina N, Papahadjopoulos-Sternberg B, D'Souza GG. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proceedings of the National Academy of Sciences of the United States of America. 100: 1972-7. PMID 12571356 DOI: 10.1073/Pnas.0435906100 |
0.378 |
|
| 2003 |
Lukyanov AN, Gao Z, Mazzola L, Torchilin VP. Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice. Pharmaceutical Research. 19: 1424-9. PMID 12425458 DOI: 10.1023/A:1020488012264 |
0.429 |
|
| 2002 |
Levchenko TS, Rammohan R, Lukyanov AN, Whiteman KR, Torchilin VP. Liposome clearance in mice: The effect of a separate and combined presence of surface charge and polymer coating International Journal of Pharmaceutics. 240: 95-102. PMID 12062505 DOI: 10.1016/S0378-5173(02)00129-1 |
0.311 |
|
| 2002 |
Torchilin VP. PEG-based micelles as carriers of contrast agents for different imaging modalities. Advanced Drug Delivery Reviews. 54: 235-52. PMID 11897148 DOI: 10.1016/S0169-409X(02)00019-4 |
0.325 |
|
| 2002 |
Torchilin VP, Levchenko TS, Whiteman KR, Yaroslavov AA, Tsatsakis AM, Rizos AK, Michailova EV, Shtilman MI. Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification. Biomaterials. 22: 3035-44. PMID 11575478 DOI: 10.1016/S0142-9612(01)00050-3 |
0.358 |
|
| 2002 |
Gao Z, Lukyanov AN, Singhal A, Torchilin VP. Diacyllipid-Polymer Micelles as Nanocarriers for Poorly Soluble Anticancer Drugs Nano Letters. 2: 979-982. DOI: 10.1021/Nl025604A |
0.365 |
|
| 2001 |
Lo EH, Singhal AB, Torchilin VP, Abbott NJ. Drug delivery to damaged brain. Brain Research. Brain Research Reviews. 38: 140-8. PMID 11750930 DOI: 10.1016/S0165-0173(01)00083-2 |
0.33 |
|
| 2001 |
Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. Journal of Controlled Release : Official Journal of the Controlled Release Society. 73: 137-72. PMID 11516494 DOI: 10.1016/S0168-3659(01)00299-1 |
0.463 |
|
| 2001 |
Torchilin VP, Iakoubov LZ, Estrov Z. Antinuclear autoantibodies as potential antineoplastic agents. Trends in Immunology. 22: 424-7. PMID 11473830 DOI: 10.1016/S1471-4906(01)01984-6 |
0.309 |
|
| 2001 |
Torchilin VP. Polymeric contrast agents for medical imaging. Current Pharmaceutical Biotechnology. 1: 183-215. PMID 11467336 DOI: 10.2174/1389201003378960 |
0.318 |
|
| 2001 |
Khaw BA, daSilva J, Vural I, Narula J, Torchilin VP. Intracytoplasmic gene delivery for in vitro transfection with cytoskeleton-specific immunoliposomes. Journal of Controlled Release : Official Journal of the Controlled Release Society. 75: 199-210. PMID 11451510 DOI: 10.1016/S0168-3659(01)00364-9 |
0.349 |
|
| 2001 |
Torchilin VP, Rammohan R, Weissig V, Levchenko TS. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors Proceedings of the National Academy of Sciences of the United States of America. 98: 8786-8791. PMID 11438707 DOI: 10.1073/Pnas.151247498 |
0.43 |
|
| 2001 |
Torchilin VP, Levchenko TS, Lukyanov AN, Khaw BA, Klibanov AL, Rammohan R, Samokhin GP, Whiteman KR. p-nitrophenylcarbonyl-PEG-PE-liposomes: Fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups Biochimica Et Biophysica Acta - Biomembranes. 1511: 397-411. PMID 11286983 DOI: 10.1016/S0005-2728(01)00165-7 |
0.352 |
|
| 2000 |
Khaw BA, Torchilin VP. 10 targeting in myocardial infarction. Methods in Molecular Medicine. 25: 159-91. PMID 21318846 DOI: 10.1385/1-59259-075-6:159 |
0.373 |
|
| 2000 |
Weissig V, Babich J, Torchilin V. Long-circulating gadolinium-loaded liposomes: potential use for magnetic resonance imaging of the blood pool. Colloids and Surfaces B: Biointerfaces. 18: 293-299. PMID 10915951 DOI: 10.1016/S0927-7765(99)00155-1 |
0.349 |
|
| 2000 |
Dellian M, Yuan F, Trubetskoy VS, Torchilin VP, Jain RK. Vascular permeability in a human tumour xenograft: molecular charge dependence. British Journal of Cancer. 82: 1513-8. PMID 10789717 DOI: 10.1054/Bjoc.1999.1171 |
0.314 |
|
| 1999 |
Torchilin VP. Biotin-conjugated polychelating agent. Bioconjugate Chemistry. 10: 146-9. PMID 9893977 DOI: 10.1021/Bc9800567 |
0.308 |
|
| 1998 |
Dalkara S, Petrov A, Trubetskoy VS, Khaw BA, Torchilin VP. Disulfide cross-linked Fab-aggregates: preparation and biodistribution. Journal of Drug Targeting. 6: 45-52. PMID 9769020 DOI: 10.3109/10611869808997880 |
0.34 |
|
| 1998 |
Iakoubov LZ, Torchilin VP. Nucleosome-releasing treatment makes surviving tumor cells better targets for nucleosome-specific anticancer antibodies. Cancer Detection and Prevention. 22: 470-5. PMID 9727629 DOI: 10.1046/J.1525-1500.1998.00055.X |
0.387 |
|
| 1998 |
Trubetskoy VS, Whiteman KR, Torchilin VP, Wolf GL. Massage-induced release of subcutaneously injected liposome-encapsulated drugs to the blood. Journal of Controlled Release : Official Journal of the Controlled Release Society. 50: 13-9. PMID 9685868 DOI: 10.1016/S0168-3659(97)00104-1 |
0.339 |
|
| 1998 |
Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proceedings of the National Academy of Sciences of the United States of America. 95: 4607-12. PMID 9539785 DOI: 10.1073/Pnas.95.8.4607 |
0.351 |
|
| 1998 |
Torchilin VP. Polymer-coated long-circulating microparticulate pharmaceuticals. Journal of Microencapsulation. 15: 1-19. PMID 9463803 DOI: 10.3109/02652049809006831 |
0.333 |
|
| 1998 |
Khaw BA, Narula J, Vural I, Torchilin VP. Cytoskeleton-specific immunoliposomes: sealing of hypoxic cells and intracellular delivery of DNA International Journal of Pharmaceutics. 162: 71-76. DOI: 10.1016/S0378-5173(97)00414-6 |
0.339 |
|
| 1997 |
Torchilin VP. Affinity liposomes in vivo: factors influencing target accumulation. Journal of Molecular Recognition : Jmr. 9: 335-46. PMID 9174907 DOI: 10.1002/(SICI)1099-1352(199634/12)9:5/6<335::AID-JMR309>3.0.CO;2-0 |
0.32 |
|
| 1997 |
Gref R, Minamitake Y, Peracchia MT, Domb A, Trubetskoy V, Torchilin V, Langer R. Poly(ethylene glycol)-coated nanospheres: potential carriers for intravenous drug administration. Pharmaceutical Biotechnology. 10: 167-98. PMID 9160372 DOI: 10.1007/0-306-46803-4_6 |
0.364 |
|
| 1997 |
Chen H, Torchilin V, Langer R. Lectin-bearing polymerized liposomes as potential oral vaccine carriers. Pharmaceutical Research. 13: 1378-83. PMID 8893278 DOI: 10.1023/A:1016030202104 |
0.337 |
|
| 1997 |
Torchilin VP. Targeting of Liposomes Within Cardiovascular System Journal of Liposome Research. 7: 433-454. DOI: 10.3109/08982109709035511 |
0.398 |
|
| 1997 |
Torchilin VP. Surface-modified liposomes in gamma- and MR-imaging Advanced Drug Delivery Reviews. 24: 301-313. DOI: 10.1016/S0169-409X(96)00472-3 |
0.339 |
|
| 1996 |
Torchilin VP, Narula J, Halpern E, Khaw BA. Poly(ethylene glycol)-coated anti-cardiac myosin immunoliposomes: factors influencing targeted accumulation in the infarcted myocardium. Biochimica Et Biophysica Acta. 1279: 75-83. PMID 8624365 DOI: 10.1016/0005-2736(95)00248-0 |
0.36 |
|
| 1996 |
Torchilin VP, Trubetskoy VS, Whiteman KR, Caliceti P, Ferruti P, Veronese FM. New synthetic amphiphilic polymers for steric protection of liposomes in vivo. Journal of Pharmaceutical Sciences. 84: 1049-53. PMID 8537880 DOI: 10.1002/Jps.2600840904 |
0.317 |
|
| 1996 |
Iakoubov L, Rokhlin O, Torchilin V. Anti-nuclear autoantibodies of the aged reactive against the surface of tumor but not normal cells. Immunology Letters. 47: 147-9. PMID 8537094 DOI: 10.1016/0165-2478(95)00066-E |
0.314 |
|
| 1996 |
Chen H, Torchilin V, Langer R. Polymerized liposomes as potential oral vaccine carriers: Stability and bioavailability Journal of Controlled Release. 42: 263-272. DOI: 10.1016/0168-3659(96)01459-9 |
0.355 |
|
| 1995 |
Timofeev BA, Bolotin IM, Stepanova LP, Bogdanov AA, Georgiu K, Malyshev SN, Petrovsky VV, Klibanov AL, Torchilin VP. Liposomal diamidine (imidocarb): preparation and animal studies. Journal of Microencapsulation. 11: 627-32. PMID 7884627 DOI: 10.3109/02652049409051112 |
0.346 |
|
| 1995 |
Torchilin VP. Immunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agents. Immunomethods. 4: 244-58. PMID 7820455 DOI: 10.1006/Immu.1994.1027 |
0.396 |
|
| 1995 |
Khaw BA, Torchilin VP, Vural I, Narula J. Plug and seal: prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin-liposomes. Nature Medicine. 1: 1195-8. PMID 7584994 DOI: 10.1038/Nm1195-1195 |
0.308 |
|
| 1995 |
Torchilin VP, Trubetskoy VS. In vivo visualizing of organs and tissues with liposomes Journal of Liposome Research. 5: 795-812. DOI: 10.3109/08982109509012682 |
0.341 |
|
| 1995 |
Torchilin VP. Targeting of drugs and drug carriers within the cardiovascular system Advanced Drug Delivery Reviews. 17: 75-101. DOI: 10.1016/0169-409X(95)00042-6 |
0.414 |
|
| 1995 |
Trubetskoy VS, Torchilin VP. Use of polyoxyethylene-lipid conjugates as long-circulating carriers for delivery of therapeutic and diagnostic agents Advanced Drug Delivery Reviews. 16: 311-320. DOI: 10.1016/0169-409X(95)00032-3 |
0.429 |
|
| 1994 |
Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science (New York, N.Y.). 263: 1600-3. PMID 8128245 DOI: 10.1126/Science.8128245 |
0.373 |
|
| 1994 |
Torchilin VP, Shtilman MI, Trubetskoy VS, Whiteman K, Milstein AM. Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo. Biochimica Et Biophysica Acta. 1195: 181-4. PMID 7918561 DOI: 10.1016/0005-2736(94)90025-6 |
0.315 |
|
| 1994 |
Torchilin VP, Omelyanenko VG, Papisov MI, Bogdanov AA, Trubetskoy VS, Herron JN, Gentry CA. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochimica Et Biophysica Acta. 1195: 11-20. PMID 7918551 DOI: 10.1016/0005-2736(94)90003-5 |
0.32 |
|
| 1994 |
Torchilin VP, Trubetskoy VS, Milshteyn AM, Canillo J, Wolf GL, Papisov MI, Bogdanov AA, Narula J, Khaw BA, Omelyanenko VG. Targeted delivery of diagnostic agents by surface-modified liposomes Journal of Controlled Release. 28: 45-58. DOI: 10.1016/0168-3659(94)90152-X |
0.367 |
|
| 1993 |
Trubetskoy VS, Narula J, Khaw BA, Torchilin VP. Chemically optimized antimyosin Fab conjugates with chelating polymers: importance of the nature of the protein-polymer single site covalent bond for biodistribution and infarction localization. Bioconjugate Chemistry. 4: 251-5. PMID 8218480 DOI: 10.1021/Bc00022A001 |
0.343 |
|
| 1993 |
Torchilin VP, Lukyanov AN, Klibanov AL, Omelyanenko VG. Interaction between oleic acid-containing pH-sensitive and plain liposomes. Fluorescent spectroscopy studies. Febs Letters. 305: 185-8. PMID 1299612 DOI: 10.1016/0014-5793(92)80663-2 |
0.336 |
|
| 1993 |
Torchilin V, Trubetskoy V, Narula J, Khaw B, Klibanov A, Slinkin M. Chelating polymer modified monoclonal antibodies for radioimmunodiagnostics and radioimmunotherapy Journal of Controlled Release. 24: 111-118. DOI: 10.1016/0168-3659(93)90171-Z |
0.309 |
|
| 1992 |
Torchilin VP, Klibanov AL, Huang L, O'Donnell S, Nossiff ND, Khaw BA. Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 6: 2716-9. PMID 1612296 DOI: 10.1096/Fasebj.6.9.1612296 |
0.363 |
|
| 1992 |
Glushakova SE, Omelyanenko VG, Lukashevitch IS, Bogdanov AA, Moshnikova AB, Kozytch AT, Torchilin VP. The fusion of artificial lipid membranes induced by the synthetic arenavirus 'fusion peptide'. Biochimica Et Biophysica Acta. 1110: 202-8. PMID 1390849 DOI: 10.1016/0005-2736(92)90360-X |
0.306 |
|
| 1991 |
Mori A, Klibanov AL, Torchilin VP, Huang L. Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. Febs Letters. 284: 263-6. PMID 2060647 DOI: 10.1016/0014-5793(91)80699-4 |
0.353 |
|
| 1991 |
Bogdanov AA, Gordeeva LV, Baibakov BA, Margolis LB, Torchilin VP. Restoration of adhesive potentials of Ehrlich ascites carcinoma cells by modification of plasma membrane. Journal of Cellular Physiology. 147: 182-90. PMID 2037621 DOI: 10.1002/Jcp.1041470123 |
0.32 |
|
| 1991 |
Klibanov AL, Maruyama K, Beckerleg AM, Torchilin VP, Huang L. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochimica Et Biophysica Acta. 1062: 142-8. PMID 2004104 DOI: 10.1016/0005-2736(91)90385-L |
0.414 |
|
| 1991 |
Klibanov AL, Khaw BA, Nossiff N, O'Donnell SM, Huang L, Slinkin MA, Torchilin VP. Targeting of macromolecular carriers and liposomes by antibodies to myosin heavy chain. The American Journal of Physiology. 261: 60-5. PMID 1928455 DOI: 10.1152/Ajplung.1991.261.4.L60 |
0.36 |
|
| 1990 |
Klibanov AL, Maruyama K, Torchilin VP, Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. Febs Letters. 268: 235-7. PMID 2384160 DOI: 10.1016/0014-5793(90)81016-H |
0.387 |
|
| 1990 |
Holmberg E, Maruyama K, Kennel S, Klibanov A, Torchilin V, Ryan U, Huang L. Target-Specific Binding of Immunoliposomes in Vivo Journal of Liposome Research. 1: 393-406. DOI: 10.3109/08982109009036003 |
0.373 |
|
| 1989 |
Gordeeva LV, Bogdanov AA, Baibakov BA, Torchilin VP, Margolis LB. Adhesion defect of ascites cells corrected with membrane-bound attachment molecules. Febs Letters. 241: 185-7. PMID 3197831 DOI: 10.1016/0014-5793(88)81057-3 |
0.304 |
|
| 1989 |
Bogdanov AA, Gordeeva LV, Torchilin VP, Margolis LB. Lectin-bearing liposomes: differential binding to normal and to transformed mouse fibroblasts. Experimental Cell Research. 181: 362-74. PMID 2924795 DOI: 10.1016/0014-4827(89)90094-3 |
0.324 |
|
| 1989 |
Khaw BA, Torchilin VP, Klibanov AL, Nossiff ND, Powers JB, Strauss HW, Haber E. Modification of monoclonal antimyosin antibody: enhanced specificity of localization and scintigraphic visualization in acute experimental myocardial infarction. Journal of Molecular and Cellular Cardiology. 21: 31-5. PMID 2733028 DOI: 10.1016/0022-2828(89)90835-3 |
0.314 |
|
| 1989 |
Klibanov AL, Bogdanov AA, Torchilin VP, Huang L. Biotin-Bearing pH-Sensitive Liposomes: High-Affinity Binding to Avidin Layer Journal of Liposome Research. 1: 233-244. DOI: 10.3109/08982108909035994 |
0.309 |
|
| 1988 |
Bogdanov AA, Klibanov AL, Torchilin VP. Protein immobilization on the surface of liposomes via carbodiimide activation in the presence of N-hydroxysulfosuccinimide. Febs Letters. 231: 381-4. PMID 3360144 DOI: 10.1016/0014-5793(88)80854-8 |
0.306 |
|
| 1988 |
Trubetskaya OV, Trubetskoy VS, Domogatsky SP, Rudin AV, Popov NV, Danilov SM, Nikolayeva MN, Klibanov AL, Torchilin VP. Monoclonal antibody to human endothelial cell surface internalization and liposome delivery in cell culture. Febs Letters. 228: 131-4. PMID 3342871 DOI: 10.1016/0014-5793(88)80601-X |
0.337 |
|
| 1988 |
Trubetskoy VS, Dormeneva EV, Tsibulsky VP, Repin VS, Torchilin VP. Use of enzyme label for quantitative evaluation of liposome adhesion on cell surface: studies with J774 macrophage monolayers. Analytical Biochemistry. 172: 185-9. PMID 2847579 DOI: 10.1016/0003-2697(88)90430-7 |
0.338 |
|
| 1988 |
Burkhanov S, Kosykh V, Repin V, Saatov T, Torchilin V. Interaction of liposomes of different phospholipid and ganglioside composition with rat hepatocytes International Journal of Pharmaceutics. 46: 31-34. DOI: 10.1016/0378-5173(88)90006-3 |
0.363 |
|
| 1988 |
Torchilin V, Schlarb B, Klibanov A, Ivanov N, Ringsdorf H. Liposome-polymer systems. Introduction of liposomes into a polymer gel and preparation of the polymer gel inside a liposome Polymer Science U.S.S.R.. 30: 2307-2312. DOI: 10.1016/0032-3950(88)90369-3 |
0.303 |
|
| 1987 |
Trubetskoy VS, Berdichevsky VR, Efremov EE, Torchilin VP. On the possibility of the unification of drug targeting systems. Studies with liposome transport to the mixtures of target antigens. Biochemical Pharmacology. 36: 839-42. PMID 3494451 DOI: 10.1016/0006-2952(87)90172-9 |
0.4 |
|
| 1987 |
PAPISOV M, SAVELYEV V, SERGIENKO V, TORCHILIN V. Magnetic drug targeting. I. in vivo kinetics of radiolabelled magnetic drug carriers International Journal of Pharmaceutics. 40: 201-206. DOI: 10.1016/0378-5173(87)90169-4 |
0.328 |
|
| 1986 |
Klibanov AL, Muzykantov VR, Ivanov NN, Torchilin VP. Evaluation of quantitative parameters of the interaction of antibody-bearing liposomes with target antigens. Analytical Biochemistry. 150: 251-7. PMID 4091252 DOI: 10.1016/0003-2697(85)90507-X |
0.348 |
|
| 1986 |
Petrukhina O, Ivanov N, Feldstein M, Vasil'ev A, Plate N, Torchilin V. The regulation of liposome permeability by polyelectrolyte Journal of Controlled Release. 3: 137-141. DOI: 10.1016/0168-3659(86)90074-X |
0.333 |
|
| 1986 |
Maksimenko AV, Konovalova OY, Berdichevskii VP, Arkhipova OG, Torchilin VP. In vitro andin vivo studies of native and dextran-modified hyaluronidase Bulletin of Experimental Biology and Medicine. 102: 1545-1547. DOI: 10.1007/Bf00854685 |
0.339 |
|
| 1986 |
Trubetskoi VS, Berdichevskii VR, Efremov EE, Torchilin VP, Smirnov VN. Liposome transport to target antigens as a possible way of standardizing targeted drug transport Bulletin of Experimental Biology and Medicine. 102: 1219-1222. DOI: 10.1007/Bf00842239 |
0.339 |
|
| 1985 |
Maksimenko AV, Torchilin VP. Water-soluble urokinase derivatives with increased affinity to the fibrin clot. Thrombosis Research. 38: 289-95. PMID 4024044 DOI: 10.1016/0049-3848(85)90157-4 |
0.363 |
|
| 1985 |
Maksimenko AV, Torchilin VP. Water-soluble urokinase derivatives of combined action. Thrombosis Research. 38: 277-88. PMID 4024043 DOI: 10.1016/0049-3848(85)90156-2 |
0.328 |
|
| 1984 |
Papisov MI, Samokhin GP, Smirnov MD, Torchilin VP, Smirnov VN. Possible use of ferromagnetic materials for targeted drug transport Bulletin of Experimental Biology and Medicine. 98: 1289-1291. DOI: 10.1007/Bf00804326 |
0.331 |
|
| 1983 |
Lasch J, Berdichevsky VR, Torchilin VP, Koelsch R, Kretschmer K. A method to measure critical detergent parameters. Preparation of liposomes. Analytical Biochemistry. 133: 486-91. PMID 6638509 DOI: 10.1016/0003-2697(83)90114-8 |
0.306 |
|
| 1983 |
Khaw BA, Torchilin VP, Berdichevskii VR, Barsukov AA, Klibanov AL, Smirnov VN, Haber E. Enhancing specificity and stability of targeted liposomes by coincorporation of sialoglycoprotein and antibody on liposomes Bulletin of Experimental Biology and Medicine. 95: 776-781. DOI: 10.1007/Bf00834903 |
0.379 |
|
| 1982 |
Torchilin V, Klibanov A, Smirnov V. Phosphatidylinositol may serve as the hydrophobic anchor for immobilization of proteins on liposome surface Febs Letters. 138: 117-120. DOI: 10.1016/0014-5793(82)80408-0 |
0.326 |
|
| 1981 |
Torchilin V, Klibanov A. Immobilization of proteins on liposome surface Enzyme and Microbial Technology. 3: 297-304. DOI: 10.1016/0141-0229(81)90003-X |
0.325 |
|
| 1979 |
Torchilin VP, Khaw BA, Smirnov VN, Haber E. Preservation of antimyosin antibody activity after covalent coupling to liposomes. Biochemical and Biophysical Research Communications. 89: 1114-9. PMID 496941 DOI: 10.1016/0006-291X(79)92123-5 |
0.324 |
|
| Show low-probability matches. |